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Bio-synthesised LytC protein kills bacteria and the 
study of protein dynamics in B. subtilis 
Zusammenfassung 
Eine Vielzahl von Antibiotika greifen in die Zellwandsynthese ein. Gegen fast alle 
gängigen Antibiotika existieren Resistenzen, die von einem Bakterium in das andere 
weitergegeben werden können. Daher wollten wir eine alternative Strategie verfolgen 
und Zellwand-degradierende Enzyme einsetzten, um Bakterien durch externe Zugabe 
zu lysieren. LytC iste in sogenanntes Autolysin von Bacillus subtilis, das in der Lage 
ist, Brüche in die Zellwand einzuführen, und ist ein Kandidat für unsere Strategie. Ich 
habe das lytC Gen kloniert und das Protein in E. coli Zellen überproduziert, und 
anschließend aufgereinigt. Um die Funktion der verschiedenen LytC Domänen zu 
untersuchen, haben wir unterschiedliche Konstrukte von LytC hergestellt. LytC 
besitzt eine “low complexity region” (LCR), vier Zellwand-Bindedomänen (CWB) 
und eine funktionale Hydrolase Domäne. Ich habe das Gram negative Bakterium E. 
coli und den Gram positiven Organismus B. subtilis verwendet, um zu untersuchen, 
ob extern zugegebenes LytC zur Zelllyse führen kann. Die Ergebnisse zeigten dass 
LytC effizient das Wachstum beider Organismen hemmen kann, wobei dieser Effekt 
nur in der exponentiellen Wachstumsphase zu beobachten war. Eine C-terminale 
Fusion von LytC mit einem Strepavidin-tag konnte effizient überproduziert und 
gereinigt werden, ein N-terminaler nicht.   Die Überexpression von LytC führte zu 
einem schnellen Absinken der optischen Dichte, eine Stunde nach Induktion der 
Transkription. Das LytCF6 Konstrukt bestand nur aus der Hydrolase Domäne und 
konnte Zelllyse herbeiführen, was zeigt, dass die CWD und die LCR Domänen nicht 
essentiell für die Aktivität sind. Kontrollversuche mit BSA oder Elutionspuffer 
belegten, dass die Aktivität spezifisch für LytC ist. Eine Deletion von 22 
Aminosäuren von C-Terminus der funktionalen Domäne führten zu einer starken 
Reduktion der lytischen Aktivität, was zusätzlich belegt, dass die 
wachstumshemmende Aktivität von LytCF2 stammt. 
Im zweiten Teil der Arbeit wurden die Lokalisation und die 
Einzelmolekülbewegungen von Proteinen MreB, MreC, MreD, Pbp1A und RodZ, die 
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an der Zellmorphologie in vielen Bakterien beteiligt sind, und den Untereinheiten der 
Pyruvat-Dehydrogenase (PDH) und der Phosphofruktokinase (PfkA) als zytosolische 
Proteine untersucht. Die Morphologie-Proteine sind entweder Membran-integral, oder 
Membran-assoziiert, was die Lokalisation der fluoreszierenden Fusionsproteine 
bestätigte. MreB aus B. subtilis und aus E. coli bildete, wie zuvor beschrieben, 
filamentöse Strukturen an der Zellmembran aus.  Eine Reduktion des 
Expressionsniveaus von MreB führte zur Ausbildung kurzer Filamente und diffuser 
Aggregate. MreC und MreD interagieren mit MreB und lokalisierten in punktuellen 
Mutsren innerhalb der Membran. Die PDH Untereinheiten PdhB, PdhC und die PfkA 
wiesen homogene Lokalisation in der Zelle auf, im Einklang mit einer zytosolischen 
Enzym-Funktion. Interessanterweise lokalisierte PdhA an nur einem Zellpol in zwei 
Dritteln der Zellen, und PdhD wies zwei Lokalisationsmuster auf, ein homogen 
zytosolisches, und eines, dass mit der Lokalisation der Chromosomen im Nukleoid 
überein stimmte. Dem entsprechend haben zwei der vier Untereinheiten der PDH eine 
spezifische Lokalisation in B. subtilis Zellen.  
Durch Einzelmolekül-Fluoreszenzmikroskopie und automatisierter 
Molekülverfolgung konnte bestimmt werden, dass MreB Moleküle zwei Populationen 
ausbilden, eine eher immobile Population, die in den filamentösen Strukturen 
vorhanden ist, und eine bewegliche aus diffundierenden Molekülen. Die Mehrheit der 
MreB Moleküle ist immobil und damit in filamentöser Struktur. Auch MreC, MreD 
und RodZ, sowie Pbp1A und die PDH Untereinheiten wiesen eine statische und eine 
dynamische Population auf, nur PfkA zeigte zwei dynamische Populationen, die 
vermutlich aus einer Population langsamer und schnell diffundierender Proteine 
besteht. Die Diffusionsgeschwindigkeit der der dynamischen MreB Moleküle ist 
deutlich niedriger als die der PfkA Moleküle, was vermuten lässt, dass MreB 
hauptsächlich entlang der Membran diffundiert, was die Diffusion verringert. Die E2 
Untereinheit der PDH, PdhC, scheint die zentrale Untereinheit der PDH zu sein, da 
sie die geringste Diffusionskonstante der vier Untereinheiten aufwies, und daher die 
meisten PdhC Moleküle im Komplex gebunden sind, während die übrigen in höherem 
Masse zwischen freier und gebundener Form wechseln. 
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Abstract 
For many years, efforts for discovering new antibiotics were mainly focused on the 
inhibitors of the cell wall synthesis machinery. We set out to find other factors that 
target the cell wall by making use of the cell wall degradation enzymes, which lyse 
the cell wall and therefore potentially kill bacteria. LytC is an autolysin from B. 
subtilis, which is capable of degrading the bacterial cell wall and make it a potential 
candidate antibiotic. In this dissertation, I cloned the B. subtilis lytC gene and over-
expressed LytC protein in E. coli. In order to characterize the function of different 
LytC regions, we designed different constructs of lytC. I used the Gram-negative 
bacterium E. coli and Gram-positive B. subtilis to test if LytC can degrade the cell 
wall components when used as an external additive in cell medium. Different 
constructs of purified LytC protein were used, the results showed that LytC constructs 
can efficiently and greatly inhibit the growth of E. coli and B. subtilis, yet it is only 
effective for exponentially growing cells. The cell wall of stationary cells was more 
resistant to LytC and cell lysis was not observed. I proved that the C-terminal fusion 
of LytC with a strep-tag can be successfully over-expressed and purified while the N-
terminal fusion cannot. Overexpression of LytC leads to a fast drop in OD600 after one 
hour induction with 0.5 mM IPTG. The construct of LytCF6 only contains the 
functional region and the purified protein can still function like full length protein, 
which means the four cell wall binding (CWB) and the „low complexity 
region“ (LCR) domains are not necessary for LytC activity. I used strep elution buffer 
with BSA (bovine serum albumin) as control to verify that it is the LytC protein that 
is responsible for cell growth inhibition. I deleted 22 amino acids from the C-terminus 
of the functional region, and protein activity of this partially deleted LytCF2R2 was 
compared with LytCF2 (which has the full length of functional region). As a result, 
LytCF2R2 lost almost half of the protein activity in comparison to LytCF2. This 
further demonstrates that LytCF2 contains the functional region and the deletion of it 
can result in loss of activity. 
We reviewed the localization and the single molecule trajectories of proteins 
(MreBCD, Pbp1A, RodZ and PDH complex) in exponentially grown B. subtilis cells. 
Phosphofructokinase (PfkA), which is a fast moving protein, was used as a control for 
MreB in the single molecule tracking study. In the protein localization study, we 
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found that MreB, MreC, MreD, RodZ and Pbp1A are localized along the cell 
membrane and have a similar localization pattern. The results indicate that MreB, 
MreC, MreD, RodZ and Pbp1A are membrane proteins. We confirmed the 
phenomenon that MreB forms discontinuous filaments structure underneath the cell 
membrane, both in B. subtilis and in E. coli. Upon reduction in its expression level, 
MreB forms patchy and short filament structures in B. subtilis. MreC and MreD also 
form patchy spots structures besides the membrane staining pattern. From our 
calculation, two thirds cells have PdhA localized at one cell pole, one third of the cells 
does not contain PdhA spots. The localization studies of PdhB, PdhC and PfkA 
showed that they are all uniformly distributed within the cytoplasm of the cell, which 
indicates they are cytoplasmic proteins. PdhD has two localization patterns, one is the 
same as chromosome DNA staining, and the other one is uniformly distributed within 
the cytoplasm.  
We found single molecules of MreB are composed of two populations. One is the 
immobile population that forms the filamentous structures. The other one is the 
mobile population that freely diffuses within the cell. The same conclusions apply to 
the Pbp1A and PDH subunits proteins, as well as for the MreB colocalized proteins 
(MreC, MreD and RodZ). The single molecules of the PfkA compose two mobile 
populations. The fraction and movement speed of MreB mobile single molecules are 
lower than those of PfkA. We also deduced that MreB is a membrane-associated 
protein and that PdhC (E2 subunit) is the core of PDH complex from our data analysis, 
because the fraction and diffusion coefficient of mobile PdhC single molecules are the 
slowest of the four PDH subunits. 
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1 Introduction 
1.1 Cell wall 
Bacteria have different cell shapes and sizes, the external cell wall plays an essential 
role in cell shape determination. A great number of bacterial species are cylindrical 
(or rod-shaped). In most cases, cell growth occurs along the longitudinal axis, while 
keeping a fixed diameter (usually 0.5-1.5 µm) [1]. The peptidoglycan (PG) cell wall is 
the major determinant of cell shape [2]. The composition of the cell wall is shown as 
Figure 1 [3]. 
 
Figure 1. Schematic cartoon showing the composition and structure of peptidoglycan, which 
is a major component of the bacterial cell wall. Image was taken and modified from the work 
of Kristi Lazar and Suzanne Walker, 2002 [3]. 
The process of cell wall synthesis is a target for several antibiotics. The biosynthesis 
of the cell wall starts from the formation of soluble precursors which are produced by 
cytoplasmic reactions that are catalyzed by MurA-MurF [4]. This is followed by the 
production of lipid-linked precursors Lipid I and Lipid II that are catalyzed by MraY 
and membrane-associated protein MurG at the inner face of the cytoplasmic 
membrane. Lipid II is then translocated across the membrane and incorporated into 
the existing cell wall of the periplasm of Gram-negative bacteria or outside the 
membrane of Gram-positive bacteria [5]. Penicillin binding proteins (PBPs) catalyze 
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the reactions of transglycosylation (polymerization of the glycan strand) and 
transpeptidation (cross-linking between glycan chains) [6, 7]. In both rod-shaped and 
spherical bacteria, the synthesis of PG precursors, hydrolysis and insertion of PG 
require the coordination of several enzymes from multiple subcellular compartments. 
The new cell wall synthesis of spherical bacteria occurs during cell division while 
rod-shaped bacteria require an elongation growth phase between division circles [8]. 
1.2 Peptidoglycan (PG) 
The peptidoglycan (PG or murein) of Gram-positive and Gram-negative bacteria has 
different amino acid composition and PG layer thickness [9, 10]. The main function 
of PG is to preserve cell integrity by withstanding the internal osmotic pressure [11]. 
During the cell division, PG components are inserted along the length of the cell, and 
the integrity of the cell wall is maintained by the simultaneous insertion of new 
glycan strands and hydrolysis of pre-existing ones [8]. PG synthesis occurs during 
two developmental phases: i) along the length of the cell during the cell elongation; ii) 
at the midcell during cell division. During the cell division of C. crescentus, MreB 
localizes to the midcell, indicating that MreB may be needed for the recruitment of 
PG synthesis enzymes at the site of division [8]. The PG sacculus forms a closed, bag-
shaped structure that surrounds the cytoplasmic membrane [10]. Degradation of the 
PG or inhibition its biosynthesis during cell growth can cause cell lysis [10]. PG is 
also a key factor for cell shape maintenance and function as a scaffold for anchoring 
other cell envelope components such as proteins and teichoic acids [12, 13]. 
In the peptide stem, there are some variations between different bacterial species (e.g. 
glycan strands and the composition of interpeptide bridge). Even in the same species, 
different growth conditions can also cause variations in the structure of PG and cell 
wall [10]. Most variations of the PG are due to modes of cross-linkage or composition 
of the interpeptide bridge [10]. Generally, cross-linkage can be divided into two 
groups [14]. I) 3-4 cross-linkage group. II) 2-4 cross-linkage group, which is only 
found among coryneform bacteria. The cross-linking reactions were catalyzed by the 
transpeptidase domain of the penicillin-binding proteins (PBPs) [6]. 
The thickness of the PG layer is not dependent by the chain length of the glycan 
strands. Gram-negative bacteria (e.g. E. coli) have a single layer of PG while Gram-
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positive bacteria (B. subtilis) have a multilayered PG and thick cell wall. For Gram-
positive and negative species, some species have long glycan strands while some 
other species have short glycan strands. In Bacilli (B. subtilis, B. licheniformis and B. 
cereus), the average chain length of glycan strands is from 50 to 250 disaccharide 
units [15-17]. Gram-negative bacteria have different chain length, but usually the 
chain length varies from 20 to 40 disaccharide units [18-20]. In E. coli, the average 
chain length of glycan strands varies with different strains and growth conditions [21]. 
The thickness of Gram-negative bacteria PG layer varies from 1.5 to 15 nm [22-26]. 
The thickness of the inner wall zone (IWZ) or periplasmic space of B. subtilis is 22 
nm. The outer wall zone (OWZ) thickness varies between different bacterial species 
and growth phase. The thickness of OWZ is between 15 to 30 nm in S. aureus, B. 
subtilis, Streptococcus gordonii and Enterococcus gallinarum [10]. Cells with less PG 
layer are more fragile to harming agents. However, cells with the ability of reducing 
PG content can deal with temporary inhibitions of cell wall biosynthesis, and have 
higher chances of survival [10, 27]. The architecture of the cell wall of Gram-positive 
cells is still poorly understood. The thick, multi-layered PG are linked to other major 
surface polymers [10]. 
The biosynthesis of PG is a complex process that involves around 20 reactions, which 
happens in cytoplasm (synthesis of nucleotide precursors), on the inner (synthesis of 
lipid-linked intermediates) and outer side (polymerization reactions) of the 
cytoplasmic membrane [4]. The stepwise assembly of the peptide stem of PG is 
ensured by Mur ligases (MurC, D, E and F) and Mpl [4]. PG synthesis involves both a 
cytoplasmic and an extracellular phase as shown in Figure 2 [3]. 
The enzymes that are responsible for PG synthesis are potential targets for antibiotic 
synthesis. However, the study of the enzymes is not well illustrated due to the lack of 
antibiotics that can inhibit the function of enzymes efficiently and specifitely. Most of 
the PG synthesis inhibitors are not capable of corss the cytoplasmic membrane [4]. 
The last generation of antibiotic mainly focuses on the inhibition of the enzymes of 
PG synthetic machinery. The inhibitors of each enzyme have been identified, 
although not all of them can be applied for clinical use [28]. However, a lot of these 
antimicrobial agents can be inactived by the resistence mechanisms of bacteria [28]. 
Hereby, we provide a new approach for developing antibiotics. Instead of seaching 
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new antibiotics that inhibit the biosynthetic machinery of PG, we investigated the 
possibility of using PG lytic enzymes that break down the cell wall. 
 
Figure 2. Model of PG biosynthesis. PG synthesis involves a cytoplasmic and an extracellular 
stages. The cytoplasmic steps can be divided into four sets of reactions [4]. The extracellular 
reactions of transglycosylation and transpeptidation are mediated by PBPs [6, 7]. Image was 
taken and modified from the work of Kristi Lazar and Suzanne Walker, 2002 [3]. 
1.3 LytC 
PG hydrolases include LytC (CwlB), LytD (CwlG), LytE (CwlF), LytF (CwlE), LytG 
(YubE), CwlO (YvcE), CwlS (YojL) and CwlK (YcdD). These PG hydrolases 
mediate diverse functions such as cell growth, cell separation, cell wall turnover, cell 
mobility, sporulation and germination of bacterial cells [29-37]. LytC, LytD, LytG 
and LytE have been confirmed to mediate cell lysis [29, 33]. Autolysins can 
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hydrolyze the bacterial cell wall and remodel the PG, and are found in all bacteria that 
have PG.  
In B. subtilis there are more than 30 autolysin genes, LytC, LytD and LytF have been 
implicated in vegetative cell separation and motility [29, 30, 32, 38, 39]. lytD and lytF 
genes are under control of σD, and 70% of LytC expression is under σD control [40-
44]. Sigma D regulates expression of genes involved in motility, chemotaxis, 
autolysin production and cell separation [30, 45-47]. Depleting the expression of these 
three autolysins showed that B. subtilis does not form separated cells and grows 
continuously in chains [48]. Exponentially growing B. subtilis are heterogeneous in 
cell morphology, some of them grow as single cells that are motile and the other cells 
are grow in multicellular, nonmotile chains [49]. The flagellar filament assembly is 
also under the control of sigma factor D [49-51]. Cells that are ON for σD express 
both the autolysin and flagellar genes and grow as separate motile cells. However, 
cells that are OFF for σD, do not express the autolysins or late flagellar genes and 
grow as nonmotile chains [38]. The expression of LytF is ON in single cells and OFF 
in long chains. B. subtilis strains with lytC or lytD mutation grow as individual cells, 
but cells with lytF mutation grow as chains. Thus LytF is the only autolysin under σD 
control that is essential for cell separation [38]. In the undomesticated strain (B. 
subtilis 3610), mutation of lytC resulted in a reduction in swarming motility. 
Furthermore, double mutation of lytC with lytD or lytF and triple mutation resulted in 
total loss of swarming motility, indicating that LytC is required for swarming mobility 
[30, 38, 43, 52]. The σD dependent autolysins are required for swarming motility, but 
are not required for flagellum biosynthesis [53]. LytF was reported to localize at the 
septa during cell division. Moreover, LytE localizes at the cell poles of vegetative 
cells and LytC localizes uniformly [53]. LytC is also needed to lyse the mother cell 
wall at the end of sporulation [54]. There must be a balance between PG synthesis and 
disassembly during cell elongation and separation. During B. subtilis cell division, the 
cell wall divides the mother cell into two daughter cells and the autolysins are needed. 
The major function of LytC is to hydrolyze the linkage of N-acetylmuramoyl-L-
alanine in PG [53]. It has been shown that lytC mutation did not cause any cell 
separation defects, the knock-out of lytC gene can increase biomass and the product 
formation in the cell [55]. The structure of LytC is predicated to be composed of a 
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transmembrane region (a.a. 7-24), a „low complexity region“ (a.a. 197-214) and three 
CWB (cell wall binding) repeat regions at the N-terminal region of LytC, and a 
catalytic region (a.a. 380-492) at the C-terminal of LytC. The CWB domains of LytC 
are not similar to the N-terminal CWB domains of LytE and LytF [53]. The CWB 
domain of LytC has been used as a CWB anchor for two artificial fusion proteins and 
both had the enzyme activity and CWB activity [56-58]. Another major vegetative 
autolysin is a 90-kDa endo-β-N-acetylglucosaminidase (LytD or CwlG), which works 
together with the amidase LytC on cell lysis. The glucosaminidase LytD and LytC 
account for around 95% of the autolytic activity of the cell [29]. LytE and LytF are 
cell separation enzymes. lytG encodes another minor PG hydrolases N-
acetylglucosaminidase [33]. Single mutant of lytE, which encodes an endopeptidase, 
results in cell growth defect and lysis reduction, but has no significant effect on the 
degradation of isolated cell wall. LytE could aid the action of LytC [31]. Furthermore, 
a lytE cwlO double mutant causes synthetic lethality due to the defect in lateral cell 
wall metabolism and cell elongation [59, 60]. Some proteins can also enhance the 
autolysin activity of LytC, such as LytA and LytB (not autolysins). SpoIID may also 
affect the activity of autolysin, because of its homology to LytB and the cell wall 
binding domain of LytC [42, 61, 62].  
S. pneumoniae LytC contains a N-terminal choline-binding module (CBW, composed 
of 11 repeats, p1-p11) and a C-terminal catalytic module (residues 268-468). Repeats 
p1-p9 are involved in choline binding (NI domain), p10 and p11 (NII domain) are 
involved in modular arrangement, p11 interacts with the catalytic module [63]. The 
model of S. pneumoniae LytC is depicted in Figure 3. 
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Figure 3. 3D structure of LytC-PG complex. A purified pneumococcal PG fragment (green 
sticks) is bound to the catalytic module (red) of LytC. Image taken from the work of 
Inmaculada Pérez-Dorado, et al., 2010 [63]. 
1.4 Penicillin Binding Proteins (PBPs) 
PBPs (penicillin-binding proteins) catalyze the polymerization of Lipid II glycan 
chains and the cross-linking of stem peptides [28, 64, 65]. In E. coli, PBP1A and 
PBP1B play an important role in the final stage of PG biosynthesis, but deletion of 
one gene will not be lethal for the bacteria [6, 66, 67]. It has been found that β-lactam 
resistance is associated to alteration in PBPs, which makes them a well known target 
for β-lactam antibiotics [68-70]. The synthesis of the peptide bridges contains a trans-
peptidation reaction [70]. Many studies showed that penicillin can prevent the 
formation of cross-linkages by interfer with the transpeptidation reaction. Further 
research suggested that a stable penicilloyl derivative was formed at the active site of 
the transpeptidase, causing a permanent inactivation [71-73]. PBPs are classified into 
two groups, the high-molecular mass (HMM) PBPs and the low-molecular mass 
(LMM) PBPs [6]. The HMM proteins (PBPs1-3) are essential proteins for cell 
elongation, cell shape determination (PBP1A/PBP2) and cell septation (PBP1B/PBP3) 
[74-79]. The HMM-PBPs contain a penicillin-binding transpeptidase and a non-
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penicillin-binding domain [6, 78]. LMM proteins (PBPs 4-7 and AmpH) can behave 
as DD-carboxypeptidases [70]. E. coli contains three class A PBPs (PBP1A, PBP1B 
and PBP1C) and two class B PBPs (PBP2 and PBP3), the major transglycosylase of E. 
coli is PBP1B [6]. PBP2 interacts with MreC and is the only murein synthase that is 
required for cylindrical growth of the sacculus. Depletion of PBPs and MreC proteins 
form spherical cells that eventually lyse [80-82]. B. subtilis has 16 PBPs, four belong 
to the class A. PBP1 is part of the cell division machinery and is required for the 
formation of the asymmetric sporulation at the septum. The other six PBPs belonged 
to class B [6, 83]. Transglycosylases are potential targets for new antibiotics. One 
reason is that they located on the outer surface of the bacterial membrane, which 
makes them accessible for antibiotics without the need to cross the membrane. There 
are several homologous of transglycosylases in each bacterial strain, so inhibitors that 
target one of these enzymes could act against several others [3]. Microorganisms 
produce a wide range of antibiotics that bind to Lipid II or other PG intermediates. 
This include glycopeptide antibiotics such as vancomycin and teicoplanin, which 
inhibit the last steps of PG synthesis [84, 85].  
1.5 MreB, RodZ, MreC and MreD 
Structure and localization of MreB 
MreB structures were depicted as extended, helical filaments that localize underneath 
the inner membrane in live cells and exhibit fast remodeling due to a high turnover 
rate. MreB was described as actin-like cytoskeletal element in bacteria based on the 
filamentous structures. However, recent studies showed that MreB is more likely to 
form discontinuous filaments that are localized along the lateral membrane [86-88]. 
These results suggested that MreB proteins might have an actin-like cytoskeletal role 
in bacteria, hence MreB filaments would play a role in cell wall synthetic, cell shape 
maintenance and other subcellular processes of rod-shaped bacteria (Figure 4) [89-92]. 
mreB genes are widely distributed in most rod-shaped or non-sperical bacteria, which 
contains at least one mreB homologue, while spherical bacteria lack mreB genes [93, 
94]. These observations led to the idea that MreB functions during cell wall growth. 
The early MreB localization experiments showed that MreB can form helix-like 
filamentous structures, peripheral spots and tilted bands [89, 93]. Several other reports 
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confirmed similar structures of MreB in different organisms [1, 95]. A great number 
of proteins that are involved in cell envelope synthetisis are associated with MreB 
proteins and mostly have a similar helical localization pattern [96-98]. MreB in E. coli 
was described to localize as heterogeneous patchy [88]. The model of MreB 
localization had changed from helical filaments to one of protein patches. In which 
the filaments are short, and in a highly dynamic state that driven by (or at least 
dependent on) PG synthesis [1]. MreB can also form filaments in vitro [99]. 
 
Figure 4. Models for MreB localization. (A) Early work indicated that MreB formed the 
helical elongated filaments (green solid and dashed lines) that along the rim of inner cell 
membrane. It was assumed that the helical filaments of MreB directed a helical pattern of new 
PG (blue shading) insertion. (B) MreB was recently depicted as discontinuous patches (green), 
which rotated circumferentially and around the long axis of cell (shown as arrows) and might 
driven by PG synthesis (blue shading). (C) Localization of GFP-MreB in a chain of 
exponentially growing B. subtilis cells. Images A and B are from the work of Jeff Errington, 
2015 [1]. Image C taken from the work of Soufo, H.J.D., et al., 2010 [100]. 
Function of MreB in cell wall synthesis 
MreB involves the determination and maintenance of cell shape and PG synthesis. 
However, the functions proteins MreC, MreD and RodZ in cell shape maintenance 
remain to be elucidated [101-105]. MreB is thought to act in organization of these 
complexes. MreB also interacts with the division machinery in some organisms such 
as E. coli [106, 107]. B. subtilis has three MreB homologues, MreB, Mbl, and MreBH, 
and mutations of these genes have different effects on cell shape [92, 108-112]. MreB 
holds structural homology with eukaryotic actins, and purified MreB shows actin like 
properties of polymerization, ATP binding and hydrolysis [113-115]. 
 10 
Cell shape is assumed to depend on MreB filament dynamics as reported previously 
[116, 117]. Cells with un-flat surface tend to have shorter MreB filaments but the 
length of filaments could increase when the cell approaches a smooth shape [1]. MreB 
was shown to interact with different components of the cell wall synthetic machinery. 
MreB filaments recruit multiple synthetic complexes and move in the direction of 
glycan-strand insertion, and a PG synthesis process moves MreB filaments. MreB 
regulation of new PG insertion results in the elongation of the existing cylindrical 
sacculus [1, 118]. By interacting with the membrane and cell wall synthesis complex, 
MreB may function as a stablizing factor (Figure 5). MreB may act to stabilize the 
location and precise movement of PG synthesis in E. coli [88]. 
 
Figure 5. Model of PG synthesis, which can be divided into three steps: i) synthesis of cell 
wall precursor in the cytosol (MurA-F); ii) MraY and MurG complete the synthesis of PG 
precursor (Lipid II) in the cytoplasme that faces the inner membrane; iii) Lipid II is 
translocated into the periplasm and incorporated into pre-existing PG (dark green), which is 
accomplished by PBPs and lytic transglycosylases. During the cell wall synthesis, MreC 
functions in the periplasm, MreD, RodA and RodZ function in the inner membrane, and 
MreB might act as a scaffold. The entire elongation machinery is shown in shades of blue. IM, 
inner membrane; OM, outer membrane. Image taken from the work of Courtney L. White and 
James W. Gober, 2012 [8]. 
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MreC, MreD and RodZ are required for the function of MreB and cell wall synthesis 
[1]. MreD is an integral bitopic membrane protein with short stretches of amino acids 
exposed to the cytoplasm. MreC has a larger periplasmic domain and an N-terminal 
tail protruding into the cytoplasm [82]. In rod-shaped bacteria, cells lacking mreB or 
its neighboring genes such as mreC and mreD result in morphology defects. Site-
specific mutagenesis of MreB also causes some morphological defects [103, 119]. 
Moreover, when MreB is depleted in the cells, the downstream PBP mislocalize and 
the PG synthesis is abrogated [120]. MreB localization pattern in vivo is similar to 
that of PBPs [121-123]. The role of MreB in cell elongation has been confirmed in 
several model organisms ( E. coli, B. subtilis and Caulobacter crescentus). MreB may 
play a key role in the similar helical localization patterns for several cell shape 
proteins, such as cytoplasmic precursor synthesizing enzymes (MurB, MurC, MurE 
and MurF), inner membrane proteins (MreD, MraY and RodA), and proteins with 
large domains outside the inner membrane (PBPs and MreC) [124-126]. Total internal 
reflection fluorescence (TIRF) microscopy was used to track the movement of GFP-
MreB and its paralogs Mbl and MreBH in B. subtilis. The GFP tagged MreB proteins 
was shown to move perpendicular to the cell length in both direction [8]. In these 
studies, patches of MreB were discontinuous and often exhibited some reversals in 
direction or crossed over one another. Movements of MreC, MreD, RodA and various 
PBPs have a similar speed and pattern as MreB and PbpH [8]. The deletion of RodA, 
RodZ and a PBP result in a gradual decrease of MreB movement, indicating that these 
three proteins may play as the driving force of MreB movement [87]. The antibiotics 
that target the PG synthesis also slowdown the movement of MreB, Mbl and PBP. 
This movement can be restored by removing the antibiotics, implicating that PG 
synthesis is required to move the PG elongation holoenzyme [86, 88].  
PG precursor synthesizing proteins (MurA-MurG and MraY) could form cytosolic 
complexes with MreB [124]. MreD is essential for lateral PG synthesis in C. 
crescentus, which interacts with the precursor synthesizing enzymes MurG and MraY. 
MreD is dependent on MreB localization along the cell length [124]. In periplasm, 
MreC of C. crescentus plays a key role in enzymes organization such as lytic 
transglycosylase MltA and the scaffolding proteins MipA and PBPs, which are 
required for PG assembly and breakdown [101, 127]. In C. crescentus, MltA and 
MipA have a similar helical localization pattern, which is dependent on MreC. MreC 
 12 
form the center of a periplasmic interaction network with various PBPs and lytic 
transglycosylases [101, 124]. MreC of both B. subtilis and E. coli can also form 
polymers in vitro [8, 80, 128]. RodZ, MreD and RodA might function as a connect 
bridge for MreB to form interactions with proteins on the outside of the membrane. 
Therefore, the PG synthesis inside the cell is connected to the outside of the cell or to 
the periplasm [8]. In B. subtilis, there is a strong interaction between MreC and MreD. 
MreB may stabilize interactions with other membrane proteins and promote the 
activity of PBPs and directly binds to several PBPs [80, 96, 99, 129]. 
RodZ 
RodZ colocalizes with MreB, which is dependent on the cytoplasmic region of RodZ, 
and this colocalization is independent from MreC, MreD, PBP2 and RodA [130, 131]. 
RodZ has an N-terminal cytoplasmic region and a periplasmic C-terminal tail. The 
crystal structure of both MreB and RodZ showed that RodZ is involved in the MreB-
coordinated network where RodZ is sandwiched between two MreB molecules [8]. 
Proper assembly of the actin cytoskeleton requires RodZ [82, 132]. It has been shown 
that the cytoplasmic domain of RodZ is required for its helical organisation in vivo 
[130, 132]. RodZ domains on both sides of the membrane play an role in cell shape 
maintenance [131]. The cytoplasmic and periplasmic domains of RodZ interact with 
other cell shape proteins at both sides of the membrane independently. There is a 
direct interaction between RodZ and MreB in its monomeric and filamentous form 
[82]. Mutations that influence this interaction causes morphological defects in E. coli 
and mislocalization of RodZ [82]. The model of RodZ interaction with MreB is 
shown as Figure 6 [82].  
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Figure 6. Colocalization model of RodZ and MreB. (A, B and C) 3D structure of RodZ 
(rainbow) in complex with MreB (blue). Grey color stands for the double-stranded DNA. (D, 
E) RodZ might anchor MreB in the membrane, RodZ localizes between MreB and the 
membrane. (D) The side-view. (E) Front-end view. Image taken from the work of Fusinita 
van den Ent, et al., 2010 [82]. 
1.6 PfkA and PdhABCD 
6-phosphofructokinase (PfkA) phosphorylates fructose 6-phosphate to fructose-1,6-
bisphosphate in glycolysis by transfering a phosphoryl group from ATP [133]. PFK 
has a homotetramer in bacteria and an octomer in yeast, and has two similar (α/β) 
lobes. The first lobe is involved in ATP binding and the other is housing both the 
substrate-binding site and the allosteric site. The tetramer subunits have 2 different 
conformations: i)'closed' state, the bound magnesium (Mg) ion bridges the phosphoryl 
groups of the enzyme products (ADP and fructose-1,6-bisphosphate); ii)'open' state, 
the Mg iron binds only the ADP [134-137]. 
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The pdhABCD operon of B. subtilis encodes the pyruvate dehydrogenase 
multienzyme complex of E1 (pyruvate decarboxylase, α subunit), E1 (pyruvate 
decarboxylase, β subunit), E2 subunit (dihydrolipoamide acetyltransferase) and E3 
subunit (lipoamide dehydrogenase), respectively. Pyruvate dehydrogenase (PDH) can 
catalyze the conversion of pyruvate into acetyl coenzyme A (acetylCoA) that produce 
one NADH and links glycolysis to diverse pathways such as Krebs, overflow 
metabolism, fatty acid biosynthesis and fermentation pathways [138]. Expression of 
the pdhABCD operon is activated by glucose, which enhances the induction of the 
operon by three folds. This indicates that glucose induction may be necessary to avoid 
pyruvate accumulation [139]. The expression of the PDH complex is increased in the 
presence of the organic acids. The pdhABCD operon is negatively regulated upon 
decoyinine treatment. The guanines located at position 1 of the transcription initiation 
sites of pdhABCD is essential for the CodY-independent negative stringent control 
[140, 141]. This operon is transcribed as a 5.2-kb transcript from the promoter located 
upstream of pdhA. It was shown that the strict negative control of newly assigned 
pdhABCD promoter was independent of CodY and likely is mediated by the decrease 
in the GTP levels, which is resulting from lysine starvation and decoyinine addition 
[141].  
There are two promoters in the pdhABCD operon. The first promoter is for the entire 
operon and the other promoter is located in front of the pdhC gene, which may 
function to ensure enough expression of E2 and E3 subunits because these subunits 
are needed in bigger amounts than E1α and E1β [142]. The PDH complex of Gram-
negative bacteria is composed of a core of 24 E2 subunits and 12 E1 and 6 E3 
subunits [143]. PDH complex of Gram-positive bacteria consists a core of 60 E2 
subunits. The E1 of Gram-negative bacteria is a homodimer, while the E1 from Gram-
positive bacteria is a heterotetramer (E1α2E1β2). The PDH complex of Gram-positive 
bacteria is encoded by genes pdhA (E1α), pdhB (E1β), pdhC (E2) and pdhD (E3) [142, 
144]. The pdhA gene is an essential gene for B. subtilis. Moreover, pdhC gene was not 
found to be essential for growth, and the inactivation of either pdhB or pdhC gene 
resulted in the inhibition of sporulation [142]. 
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1.7 Aims of reserach 
The misuse of antibiotics and the evolution of bacteria resistance to antibiotics have 
become a severe problem in the last decades. One of the resistance mechanisms is that 
bacteria can pump the antibiotics out of cell. Another mechanism is that bacteria can 
degrade the antibiotics inside or outside cells. For many years people try to find new 
antibiotics by studying the inhibitors of cell wall biosynthesis enzymes. In this 
dissertation, our way to find new antibiotics is different than the common way. Our 
goal is to develop an antibacterial agent that can hydrolyze the cell wall directly 
instead of inhibiting the function of cell wall synthesis enzymes. LytC is an autolysin 
(amidase) that can hydrolyze the linkage in PG. LytC can function in the extracellular 
space of bacteria. This will reduce the chance of developing antibiotic resistance in 
bacteria. While most traditional antibiotics inhibit the cell wall synthetic machinery, 
most traditional antibiotics cannot kill bacteria at stationary phase because the cell 
wall synthesis process has stopped. 
The cytosleletal actin-like element MreB in B. subtilis has obtained intense research 
interest since its discovery. It is well known that MreB plays an important role in cell 
shape maintenance in rod-shaped bacteria. MreB also forms helical filaments that 
localize underneath the cell membrane in B. subtilis and other bacterial cells. 
However, the structure of MreB polymerization in vivo is still in debate and the 
dynamic behavior of MreB at the single molecule level in vivo is still poorly 
understood. In this dissertation, our main aim was to characterize the localization and 
movement pattern of MreB in vivo at the single molecule level. This includes the 
single molecule movement tracking, diffusion constant (or diffusion coefficient) 
calculation, and comparison of diffusion constants between MreB and other proteins 
(MreC, MreD, RodZ, Pbp1A, PdhABCD, PfkA) in B. subtilis. We performed these 
experiments to gain more insight into the localization pattern and dynamics of MreB 
in live cells of B. subtilis and E. coli. Single molecule microscopy was used to record 
the movement of MreB. The movement of proteins (RodZ, MreC and MreD) 
associated to MreB in vivo is also one of the main interests of this study. MreB is also 
colocalize with the cell wall synthesis enzymes (Pbp1A). Therefore, the study of 
Pbp1A can help us to further understand the cell wall biosynthesis and maintenance.  
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RodZ also plays an important role in cell shape determination and cell wall synthesis, 
and it colocalizes with MreB [130, 131]. However, the function of RodZ in cell wall 
synthesis has not been clearly verified. In the future, we want to characterize RodZ in 
B. subtilis, including its localization pattern and dynamics within the membrane and 
investigate its connection to the actin-like cytoskeleton and its function in cell wall 
synthesis. 
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2 Materials and Methods 
2.1 Chemicals 
All the chemicals were purchased from Sigma, Roth, AppliChem, GE Healthcare or 
Difco. Gibson assembly (GA) mixtures, endonucleases, PCR-reagents, ligase, buffers 
and enzymes were purchased from NEB (New England Biolabs). Gel extraction of 
linear DNA fragments Kit, plasmid purification Kit, PCR purification Kit and 
chromosomal DNA extraction Kit were purchased from Qiagen, Sigma, QIAGEN and 
AnalytikJena, respectively. 
2.2 Solutions 
S750 Medium (100 ml): 10 ml 10× S750 Salts, 1 ml 100× Metals, 2 ml 50% 
Glucose/Fructose, 1 ml 5 mM 10% Glutamate, 0.4 ml 1% Casaminoacids, 1 ml 50% 
Xylose (with Fructose), 84.6 ml H2O (with Xylose). The completed medium was 
sterilized by filtration. 
10× S750 Salts (100 ml): 10.47 g MOPS, 1.32 g (NH4)2SO4, 0.68 g KH2PO4. Adjust 
the pH to 7.0 with 1 M KOH. The salts were sterilized by filtration. 
100× Metals: 0.2 mM MgCl2, 0.07 mM CaCl2, 0.1 mM ZnCl2, 0.005 mM MnCl2, 
0.002 mM HCl, 0.5 mM FeCl3, 0.1 mg/ml Thiamine-HCl. Iron was added at last to 
prevent precipitation. The metals were sterile filtered and then wrapped in aluminum 
foil to prevent contact with light and subsequent oxidization. 
LB Medium (1 L): 10 g Tryptone, 5 g Yeast Extract, 10 g NaCl, 15 g Agar (for solid 
medium). Adjust pH to 7.4 by 1 mM NaOH. Use the corresponding antibiotics. 
Sterilized by autoclaved. 
Antibiotics and other additives (final concentration): 100 µg/ml Ampicillin sodium 
salt (dissolved in ddH2O), 5 µg/ml Chloramphenicol (dissolved in ethanol), 100 µg/ml 
Spectinomycin dihydrochloride (dissolved in 50% ethanol, v/v), 0.5% (w/v) Xylose, 
0.25 mM to 1 mM Isopropyl β-D-thiogalactopyranosid (IPTG). 
 18 
2.3 Strains 
Plasmids were constructed and then amplified in the E. coli strain XL-1 Blue 
(Stratagene). E. coli BL21(DE3) (Invitrogen) was used for B. subtilis heterologous 
proteins overexpression. All constructed strains of B. subtilis in this dissertation are 
derivatives of the prototroph wild type strain PY79. All other used bacterial strains 
are listed in Table 1. 
Name Strain Genotype 
PG1 PY79 Bacillus subtilis wild type[145] 
PG105 DH5α fhuA2 Δ(argF-lacZ)U169 phoA glnV44 Φ80 
Δ(lacZ)M15 gyrA96 recA1 relA1 endA1 thi-1 hsdR17 
PG156 BL21(DE3) E. coli F– ompT gal dcm lon hsdSB(rB- mB-) λ(DE3 [lacI 
lacUV5-T7 gene 1 ind1 sam7 nin5]) 
PG145 XL1-Blue endA1 gyrA96(nalR) thi-1 recA1 relA1 lac glnV44 
F'[ ::Tn10 proAB+ lacIq Δ(lacZ)M15] hsdR17(rK- mK+) 
PG950 DH5α pPR-IBA101, AmpR 
PG575 DH5α pET-Dute-1, AmpR 
PG450 Rosetta 2 (DE3) pLysS F-ompT hsdSB(RB-mB-) gal dcm λ (DE3) [lacI lacUV5-
T7 gene 1 ind1 sam7 nin5]) pLysSRARE(CamR) 
PG2001 DH5α pSG1164-NLMV amp, cm pSG1164-New Linker-
MonomericVenus-yfp expression vector, Pxyl 
PG2276 DH5α linker-mVenus amp pSG1729-linker mVenus-yfp 
amy-locus, Pxyl 
PG2658 Bacillus subtilis PY79 Pxyl-yfp-pbp1A::amyE spec 
PG2659 Bacillus subtilis PY79 Pxyl-yfp-pbp1A (original locus) Cm 
PG2664 pfkA-yfp (original locus) pfkA-yfp (original locus)-1164 
PG1375 RecX-YFP recX-yfp-1164 
PG2984 ymfM-yfp pSG 1164, ymfM-yfp, AmpR, CmR+Xylose 
PG3007 ymfM-yfp pSG1729@amyE, yfp-ymfM, SpecR 
PG1461 yfp-mreB Pxyl-yfp-mreB::amyE, Spec, Xylose (pSG1729) 
PG1444 gfp-mreC Pxyl-gfp-mreC::amy 
PG1445 gfp-mreD Pxyl-gfp-mreD::amy 
PG1463 yfp-mreC Pxyl-yfp-mreC::amy 
PG1464 yfp-mreD Pxyl-yfp-mreD::amy 
PG2658 yfp-pbp1A Pxyl-yfp-pbp1A::amyE, Spec, Xylose (pSG1729) 
PG2659 yfp-pbp1A (original locus) Pxyl-yfp-pbp1A (original locus), Cm, pHJDS 
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PG3087 GFP-MreB St.GFP(MreB fusion) 
PG3088 GFP-MreB St.GFP-pS2131 (St GFP-MreB sandwich under PLAC) 
MC1 lytCF1-Strep lytCF1-Strep-pPR-IBA101 (PT7, AmpR) 
MC2 lytCF2-Strep lytCF2-Strep-pPR-IBA101 (PT7, AmpR) 
MC3 lytCF3-Strep lytCF3-Strep-pPR-IBA101 (PT7, AmpR) 
MC4 lytCF4-Strep lytCF4-Strep-pPR-IBA101 (PT7, AmpR) 
MC5 lytCF5-Strep lytCF5-Strep-pPR-IBA101 (PT7, AmpR) 
MC6 lytCF6-Strep lytCF6-Strep-pPR-IBA101 (PT7, AmpR) 
MC7 GST-His-lytCF1 GST-His-lytCF1-pGAT3 
MC8 GST-His-lytCF2 GST-His-lytCF2-pGAT3 
MC9 GST-His-lytCF3 GST-His-lytCF3-pGAT3 
MC10 GST-His-lytCF4 GST-His-lytCF4-pGAT3 
MC11 GST-His-lytCF5 GST-His-lytCF5-pGAT3 
MC12 GST-His-lytCF6 GST-His-lytCF6-pGAT3 
MC13 pdhA-yfp pdhA-yfp (original locus)-1164 
MC14 pdhB-yfp pdhB-yfp (original locus)-1164 
MC15 pdhC-yfp pdhC-yfp (original locus)-1164 
MC16 pdhD-yfp pdhD-yfp (original locus)-1164 
MC17 yfp-pdhA Pxyl-yfp-pdhA::amyE, Spec, Xylose (pSG1729) 
MC18 yfp-pdhB Pxyl-yfp-pdhB::amyE, Spec, Xylose (pSG1729) 
MC19 yfp-pdhC Pxyl-yfp-pdhC::amyE, Spec, Xylose (pSG1729) 
MC20 yfp-pdhD Pxyl-yfp-pdhD::amyE, Spec, Xylose (pSG1729) 
MC21 yfp-yfhH yfp-yfhH-pHJDS (original locus) 
Table 1. Strains used in this research. 
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Primers: 
All the primers used in this dissertation are listed in Table 2. 
LytCEcoRIF1 CATGAATTCGTTGGGGGAAGCAATAGATAC 
LytCEcoRIF2 CATGAATTCCCTACAAGAATTAGCGGTTCA 
LytCSacIIF3 CATCCGCGGACGGTATACAACAAGTTACCT 
LytCSacIIF4 CAT CCGCGGGATAACTCAGTGAAAAGAGTT 
LytCSacIIF5 CATCCGCGGGGTGAAACAATCTTTATTGATC 
LytC EcoRIF6 CATGAATTCATGCAGGAGAGAGTAAATAAAGCA 
LytCXhoIR CATCTCGAGTCTGTAATAAGATACTGTGCC 
GST-F1 GCCCATGGGCCACCATCACCATCACCATGTTGGGGGAAGCAATAGATAC 
GST-F2 GCCCATGGGCCACCATCACCATCACCATCCTACAAGAATTAGCGGTTCA 
GST-F3  GCCCATGGGCCACCATCACCATCACCATACGGTATACAACAAGTTACCT 
GST-F4 GCCCATGGGCCACCATCACCATCACCATGATAACTCAGTGAAAAGAGTTG 
GST-F5 GCCCATGGGCCACCATCACCATCACCATGGTGAAACAATCTTTATTGATC 
GST-F6 GCCCATGGGCCACCATCACCATCACCATCAGGAGAGAGTAAATAAAGCA 
GST-R GATCTCGAGTTATCTGTAATAAGATACTGTGCC 
lytcE342QF GGCAATGGACTCCTTCAGAAAGAAGTCAACCTTGAT 
lytcE342QR ATCAAGGTTGACTTCTTTCTGAAGGAGTCCATTGCC 
lytcE461QF GCCGAGTGTTTTAGTTCAAACTGCCTTTATCACTAAT 
lytcE461QR ATTAGTGATAAAGGCAGTTTGAACTAAAACACTCGGC 
LytCecoriCF CATGAATTCATGTTG CGTTCTTATATAAAAGTC 
LytCxhoiCR CATCTCGAGTCTCTCCTGTAAAGAATAAAA 
lytcxhoiR2 CATCTCGAGATCTGATGCATTAGTGATAAA 
pdhAFP CCTAGGATGGGTACCGGGCCCATGGCTGCAAAAACGAAAAAA 
pdhARP TGGCGCATACTGCAGGAATTCTTACTTCGACTCCTTCTGTGTATA  
pdhBFP CCTAGGATGGGTACCGGGCCCATGGCGCAAATGACAATGATT 
pdhBRP TGGCGCATACTGCAGGAATTCTTAAAATTCAAGCACTTTTCTTGC 
pdhCFP CCTAGGATGGGTACCGGGCCCGTGGCATTTGAATTTAAACTT 
pdhCRP TGGCGCATACTGCAGGAATTCTTACGCCTCCATTAAAATTAATTG 
pdhDFP CCTAGGATGGGTACCGGGCCCATGGTAGTAGGAGATTTCCCT 
pdhDRP TGGCGCATACTGCAGGAATTCTTATTTTACGATGTGAATCGGACT 
pdhAFP2 GATTCCTAGGATGGGTACCGGAATGGCTGCAAAAACGAAAAAA 
pdhARP2 CAGGCCAGATAGGCCGGGCCCCTTCGACTCCTTCTGTGTATA  
pdhBFP2 GATTCCTAGGATGGGTACCGGAATGGCGCAAATGACAATGATT 
pdhBRP2 CAGGCCAGATAGGCCGGGCCCAAATTCAAGCACTTTTCTTGC 
pdhCFP2 GATTCCTAGGATGGGTACCGGAGTGGCATTTGAATTTAAACTT 
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pdhCRP2 CAGGCCAGATAGGCCGGGCCCCGCCTCCATTAAAATTAATTG 
pdhDFP2 GATTCCTAGGATGGGTACCGGAATGGTAGTAGGAGATTTCCCT 
pdhDRP2 CAGGCCAGATAGGCCGGGCCCTTTTACGATGTGAATCGGACT 
yfhHSalIF1 CATGTCGACATGGAGAAACGATACAGTCAA 
yfhHEcoRIR1-
198 
CATGAATTCTTACAAATCAGAAGAACAAATATAAT 
Table 2. Primer collection. 
2.4 Methods 
2.4.1 Growth condition 
All the E. coli strains were grown in Luria-Bertani (LB) liquid medium or on solid LB 
agar plates with the appropriate antibiotics. The cells for protein overexpression were 
incubated on a shaking platform (INFORS-HT Multitron) with 200 rpm (rounds per 
minute) for small scale flasks or 150 rpm for 1 L culture at 37°C. All the strains used 
for microscopy were cultivated in S750 minimal medium because it provides a very 
low background of fluorescence. If not mentioned, all the B. subtilis strains were 
grown at 30°C in LB medium or S750 medium with appropriate antibiotics. The 
bacterial optical density (OD) was measured at 600 nm. 
2.4.2 Genomic DNA Extraction of B. subtilis 
Genomic DNA of B. subtilis was extracted by following the instructions of innuPREP 
Bacteria DNA Kit (analytic jena). 
2.4.3 PCR (Polymerase Chain Reaction) 
PCR was performed to amplify the desired DNA fragments. A standard PCR mixture 
is: 1 µl template DNA (genomic/plasmid1:100), 1 µl dNTPs (10 mM), 2 µl Forward 
Primer (12 mM), 2 µl Reverse Primer (12 mM), 10 µl Buffer HF (5×), 0.5 µl Phusion 
DNA polymerase, 1 µl DMSO, 32.5 µl ddH2O.  
The PCR reactions were performed in a thermocycler (Eppendorf, Mastercycler 
personal) with a standard PCR procedure as Table 3. The annealing temperature of 
Primers (forward and reverse) are dependent on the length and the melting 
temperature of oligonucleotides. The temperature was calculated as: 2×n(A/T)+ 
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4×n(G/C). The elongation time of DNA at 72°C is decided by the length of aimed 
DNA fragment, which is usually 1 min for 1 kb DNA. 
1 95 °C 5 min  
2 95 °C 30 sec ×10 cycles 
3 55 °C 30 sec 
4 72 °C 1 min (1 min/1 kb) 
5 95 °C 30 sec ×25 cycles 
6 61 °C 30 sec 
7 72 °C 1 min (1 min/1 kb) 
8 72 °C 10 min  
9 16 °C ∞  
Table 3. PCR program. 
2.4.4 Site Directed Mutagenesis 
Single site mutation at desired position in a gene sequence is performed by site 
directed mutagenesis. The gene to be mutated was first cloned into the pPR-IBA101 
vector (IBA Bio TAGnology). The desired mutation was performed by using two 
complementary primers that also bear complementarity regions to the shuttle vector. 
The mutation site was included within both primers' sequences, and the template 
plasmid was amplified with the PCR program: 95°C 2 min, 25 cycles (95°C 30 s, 50-
55°C 30 s, 72°C 5-8 min), 72°C 10 min. The machine was programmed to store the 
amplified products at 16°C till they were subsequently removed and frozen or used. 
The amplified plasmids were purified by using a PCR purification Kit (OMEGA) and 
then transformed into E. coli XL1-Blue for propagation. The plasmid was then 
purified from an overnight culture of XL1-Blue, and finally transformed into BL21 
for overexpression and subsequent protein purification. 
2.4.5 DNA Digestion, Ligation and Detection 
Restriction enzymes and buffers from New England Biolabs (NEB) were used for the 
digestion of plasmid or linear DNA. Procedures were performed according to the 
protocol of NEB. The mixture of the digestion reaction was as follows: 20 µl plasmid, 
5 µl NEB Buffer, 5 µl 1×BSA, 1 µl endonuclease. The reaction volume was 
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completed to 50 µl with ddH2O. Digested DNA was purified with Cycle Pure Kit 
(OMEGA) according to the manufacturer's protocol. For a ligation, the vector and the 
insert were added in a molar ratio of around 1:4. The concentration of DNA was 
either accurately measured by a Nanophotometer (Implem GmbH), or visually 
estimated by running an agarose gel. The ligation reaction contained: 6 µl insert DNA, 
2 µl vector, 1 µl 10× Ligation Buffer, 1 µl T4 Ligase. After the standard ligation mix 
was performed, the mixture was incubated at 16°C overnight. The ligation products 
were transformed into XL1-Blue competent cells and incubated on LB agar plates, the 
colonies were inoculated into liquid LB for plasmids extraction.  
After purification of the constructed plasmid, a test digestion was performed to check 
if the insert was correctly incorporated into the vector. A standard test digestion 
mixture consisted of: 3 µl plasmid, 1 µl NEB Buffer, 1 µl 1× BSA, and 0.2 µl 
endonuclease. The volume was completed to 10 µl with ddH2O, and incubated for 2 
hours at the adequate digestion temperatures of the enzymes indicated by NEB. 
Linear or circular DNA were separated according to their sizes (bp) and conformation 
by agarose gel electrophoresis. 1% (w/v) of agarose gel was dissolved in 1×TB buffer 
in a microwave oven. The gel was poured into a cast and left to polymerize. The DNA 
samples were mixed with 6× Loading Dye (1:5) prior to loading into the lanes of the 
gel, and the electrophoresis was performed at 130 V for 30 min. The DNA bands were 
visualized under UV light (UVP, UV transilluminator) and the linear DNA 
corresponding to a correct band size on the gel was extrated by using Cycle Pure Kit 
(OMEGA). 
TB Buffer: 48 mM Tris (hydroxymethyl) aminomethane, 38 mM Glycin, 0.035% 
(w/v) Sodium dodecylsulphate, 20% Methanol. 6×DNA Loading Dye: 20% (v/v) 
Glycerin, 6×TB Buffer, 0.001% (w/v) Bromophenol blue, 1:60000 GelRedTM 
Nucleic Acid Gel stain. 
2.4.6 E. coli competent cells preparation and transformation 
Electro-competent cells preparation: 
A single colony of E. coli XL1-Blue was inoculated from fresh plate into 15 ml liquid 
LB medium (50 ml flask) containing tetracycline, and the culture was incubated at 
37°C on a 200 rpm shaking platform overnight. 1% culture was re-inoculated into 1 L 
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LB medium (2 L flask), incubate at 37°C until an OD600 0.5~0.7 was reached. The 
culture was incubated on ice for 30 min before pelleting down by centrifugation at 
4,500 rpm for 15 min at 4°C (BECKMAN COULTER Avanti J-26 XP centrifuge, 
JLA 9,1000 rotor). The supernatant were discarded, and the pellet was re-suspended 
in 300 ml Mops solution (15%(w/v) Glycerol, 1 mM Mops). A second centrifugation 
was carried out at 4,000 rpm, at 4°C for 20 min (BECKMAN COULTER Allegra X-
15R). The cells were washed a second time in 30 ml Mops solution and then re-
suspended again in 6 ml Mops solution. 50 µl aliquots were made and stored in a -
80°C deep freezer. 
Transformation of electro-competent E. coli: 
The ligations were dialyzed (Millipore, pore-size 0.025 µm, MF-membrane filters) for 
20 min before being used for electro transformation. Dialyzed DNA was added to an 
aliquot of electro-competent cells that has been thawed on ice for 10 min. The mixed 
DNA with cells were transferred into an electroporation cuvette (Eurogentech) and 
shocked at 2500 V (Equibio, Easyject prima). The shocked products were re-
suspended by 1 ml LB medium and incubated on a 200 rpm shaker at 37°C for 1 h. 
The cells were then pelleted down, re-suspended in 50 µl LB medium, and then 
streaked on an LB agar plate with the corresponding antibiotic, and incubated at 37°C 
overnight. 
Preparation of chemical competent E. coli cells: 
1% overnight incubated pre-culture of cells were transferred into 1 L LB medium (2 L 
flask) and incubated at 37°C with low shaking speed (150 rpm) until the OD600 
reached 0.5-0.7 (usually in 1.5-2 h). The culture was incubated on ice for 30 min 
before centrifugation at 4°C with 4500 rpm for 20 min. The supernatant was 
discarded and the pellet was re-suspended with 6.75 ml cold CaCl2 solution (0.1 M) 
followed by mixing with 5.75 ml cold glycerine (50% (w/v)). The cells were split into 
aliquots of 250 µl in sterilized Eppendorf tubes and then shock-frozen in liquid 
nitrogen before being stored in a -80°C freezer. 
Transformation of chemical competent cells: 
An aliquot tube of competent cells was thawed on ice for 10 min and 1 µl of plasmid 
was added before an incubation on ice for 20 min. This step facilitates the attachment 
of plasmids to the cells. The tube containing the competent cells and the plasmids 
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mixture was heat shocked at 42°C for 1-2 min, which serves for the taking-in of 
plasmids into the cells. The tube was again incubated on ice for 10 min to recover the 
cells after the heat shock. 1 ml LB medium was added into the mixture which was 
then incubated on a shaker (200 rpm) at 37°C for 1 h. The cells were pelleted down 
by centrifugation for 30 sec at 8000 rpm, and the pellet was re-suspended with 150 µl 
LB medium. The cells were streaked on an LB agar plate with the corresponding 
antibiotic(s), and then incubated overnight at 37°C. 
2.4.7 Plasmid extraction 
Purification of plasmids from E. coli was performed either with the Plasmid DNA 
Mini Kit I (OMEGA) according to the standard protocol (for sequence) or with the 
quick and dirty plasmid extraction protocol. The sequence of DNA was determined by 
the sequencing service of Eurofins. Quick and dirty protocol is as following: 
2 ml overnight culture was pelleted down in an Eppendorf tube by centrifugation at 
8000 rpm at room temperature (RT) for 1 min. The pellet was re-suspended in 300 µl 
P1 and vortexed to assure its complete dissolution, followed by adding 300 µl P2 then 
gently mixing till the solution became homogenous, and finally 300 µl P3 were also 
mixed in gently. The mixture was incubated on ice for 5 min and then centrifuged at 
4°C, 13.000 rpm for 15 min. The supernatant was next transferred (~900µl) to a new 
Eppendorf tube and 600 µl isopropanol were added, followed by a centrifugation at 
RT, 13000 rpm for 30~45 min. The supernatant was discarded, and the pellet was 
washed with 500 µl 70% ethanol (2-4 times, 10 min, 13.000 rpm and RT centrifuge). 
The ethanol was completely discarded with a pipette and the pellet was dried and then 
re-suspended in 35 µl ddH2O and stored in a -20°C freezer. P1: 5 ml Tris-HCl (pH 8, 
50 mM), 1 ml EDTA (1 M), 10 mg RNAse A, the volume was completed with ddH2O 
to a total volume of 94 ml.  P2: 10 ml SDS (10% w/v), 20 ml NaOH (1 M), 70 ml 
ddH2O. P3: 60 ml (5 M) KC2H3O, 11.5 ml Actic Acid, 28,5 ml ddH2O. 
2.4.8 B. subtilis competence cell preparation and transformation 
Preparation of competent B. subtilis cells: 
B. subtilis is naturally competent during the early stationary phase of its growth, 
which allows it to take up exogenous DNA. If the exogenous DNA bears homology to 
regions on the chromosome, it can get incorporated into the genome via homologous 
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recombination [146, 147]. The B. subtilis strain to be driven to competence was 
streaked on LB agar plate with the corresponding antibiotic(s) at 30°C overnight. 
Fresh SpC medium with the adequate antibiotic(s) was prepared and inoculated from 
B. subtilis plate and then incubated in a shaking platform at 37°C. After 3 hours of 
growth, the OD600 was measured every 30 min until a steady read from two 
subsequent time intervals was reached indicating the entry of cells in the stationary 
phase (OD600=3~6). The culture was then transferred into 50 ml SpII and incubated at 
37°C for 90 min in a 200 rpm shaking incubator. Afterwards, the culture was 
centrifuged at 4500 rpm for 20 min at RT to pellet down the cells. 4.5 ml of the 
supernatant were collected in a separate falcon tube while the rest of the volume was 
discarded. The pellet was re-suspended in the saved 4.5 ml supernatant mixed with 
0.5 ml 50% (v/v) glycerol, and then 500 µl aliquots were transferred into sterile Eppi-
Tubes (Eppendorf) that were subsequently shock-frozen in liquid nitrogen before 
being stored in a -80°C freezer. 
Transformation of competent B. subtilis cells: 
500 µl aliquots of competent B. subtilis cells were thawed at RT. Out of the 500 µl, 
125 µl of cells were aliquoted into 3 sterile Eppendorf tubes. The first tube was used 
as a control without plasmid DNA. 3 µl plasmid DNA were added (or 0.2 µl 
chromosomal DNA) to the second tube, and 6 µl plasmid DNA (or 0.4 µl 
chromosomal DNA) were added to the third tube. The three tubes were incubated at 
37°C for 30 min on a shaking incubator. Afterwards, the cells were plated on LB agar 
plates with the appropriate antibiotic(s). The plates were incubated at 30°C overnight 
or 2 days. T-Base Buffer (10×): 20 g (NH4)2SO4, 182 g K2HPO4⋅3 H2O, 60 g KH2PO4, 
10 g Trisodium citrate⋅2 H2O. The volume was completed with ddH2O to 1 L. SpC (to 
be prepared fresh): 4 ml 10×T-Base, 0.4 ml 50% (w/v) Glucose, 0.6 ml 1.2% 
MgSO4⋅7 H2O, 1 ml 1% Casamino acids, 0.8 ml 10% Bacto Yeast extract. The 
volume was completed with ddH2O to 40 ml. SpII (to be prepared fresh): 10 ml 10×T-
Base, 1 ml 50% (w/v) Glucose, 7 ml 1.2% MgSO4⋅7 H2O, 1 ml 1% Casamino acids, 1 
ml 10% Bacto Yeast extract, 0.5 ml 0.1 M CaCl2. The volume was completed with 
ddH2O to 100 ml. 
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2.4.9 SDS Poly-acrylamide gel-electrophoresis (SDS-PAGE) 
Proteins were denatured and separated according to their molecular weight by SDS-
PAGE, which can also determine the purity of proteins. Discontinuous gels were 
prepared according to the protocol of Laemmli [148]. The thickness of the running 
Gel used was dependent on the molecular weight of protein: 12% acrylamide was 
used for bigger proteins and 15% for the smaller proteins. The stacking gel used was 
standard with 4% of acrylamide. The gels were prepared with PerfectBlue Dual Gel 
System casts. Protein samples were mixed with 2×SDS Loading Buffer and heated at 
97°C for 10 min before loading into the lanes of SDS-PAGE gel. The electrophoresis 
was done in 1×SDS running buffer with a constant voltage of 180 V. 
SDS-PAGE Running Buffer: 25 mM Tris (hydroxymethyl) aminomethane, 250 mM 
Glycine, 0.1% (w/v) Sodium dodecylsulphate. The pH was adjusted to 8.3 by HCl. 
2×Loading Buffer: 50 mM Tris (hydroxymethyl) aminomethane, 5% (v/v) Glycine, 1% 
(w/v) Sodium dodecylsulphate (SDS), 1.5% (v/v) β-mercaptoethanol, 0.05% (w/v) 
Bromophenol blue. The pH was adjusted to 6.8 by HCl. Running Gel (12%, 10 ml): 
3.3 ml ddH2O, 4.0 ml Rotiphorese Gel 30 (30% Acrylamid (w/v), 0.8% N-N'-
Methylenbisacrylamid), 2.5 ml Tris (hydroxymethyl) aminomethane pH 8.8 (1.5 M), 
0.1 ml 10% (w/v) SDS, 0.1 ml 10% (w/v) APS, 0.004 ml TEMED. Stacking gel (5%, 
4 ml): 2.7 ml ddH2O, 0.67 ml Rotiphorese Gel 30 (30% Acrylamid (w/v), 0.8% N-N'-
Methylenbisacrylamid), 0.5 ml Tris (hydroxymethyl) aminomethane pH 6.8 (1 M), 
0.04 ml 10% (w/v) SDS, 0.04 ml 10% (w/v) APS, 0.004 ml TEMED. The SDS-
PAGE gels were stained by Coomassie Brilliant Blue in staining solution at room 
temperature for 1 h on a rotating platform. Stained gels were then incubated in 
destaining solution until the unbound dye was removed. The gels were then imaged 
with an imaging system (Biorad). Staining Solution: 0.1% Coomassie Brilliant Blue 
R250, 40% Methanol, 10% Acetic Acid. Staining was done for 1-2 h or overnight. 
De-Staining Solution: 10% Methanol, 10% Acetic acid. Destaining was done for 3-10 
h. The solution was exchanged with a fresh one until the protein bands were clear 
enough to be visualized by eye. 
2.4.10 Immunoblot analysis 
Specific proteins can be more precisely detected by protein immuno-staining. After 
proteins were separated by size on SDS-PAGE gel, they were transferred to a 
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nitrocellulose membrane (Immobilon-P, Millipore) by using the semi-dry-blot method. 
Three layers of Whatman papers were placed on the cathode of Bio-Rads Trans-Blot 
SD semi-dry transfer cell after soaking them in transfer buffer. A nitrocellulose 
membrane was activated in MilliQ water and placed on three layers of Whatman 
papers. The SDS-PAGE gel was placed on top of the nitrocellulose membrane, and 
the other three layers of soaked Whatman papers were placed on the gel. After the air 
bubbles were removed, the proteins were transferred at 25 V for 30 min. After 
blotting, the un-specific sites on the membrane were blocked by incubating overnight 
in 5% (w/v) skimmed milk in PBST buffer on a shaking platform. This step is crucial 
for preventing the unspecific interactions between membrane and antibody. Primary 
antibody pre-mixed with 5% milk in PBST buffer was added to the membrane and 
incubated on a shaking platform for 1 h. The membrane was washed three times (each 
time for 10 min) in PBST buffer to get rid of the excessive antibody. The second 
antibody mixed with 5% milk in PBST buffer was added to the membrane and 
incubated for 1 h. The membrane was washed again three times by PBST buffer. 
Then the membrane was developed by incubating with the mixture of solution 1 and 
solution 2 for 2 min. After the oxidation of luminol by hydrogen peroxide with an 
emission of low intensity X-ray light, the chemiluminescence was detected with a UV 
imaging system (Molecular Imager ChemiDoc XRS System, Biorad). For the strep-
tagged proteins, only one antibody was used, and the skimmed milk was replaced by 
3% (w/v) BSA (Bovine Serum Albumin), the rest steps and chemicals were the same. 
1×PBST Buffer: 3.45 g Na2HPO4, 9 g NaH2PO4, 17.5 g NaCl, 3 ml Tween 20. 
Volume was completed to 3 L with distilled water. Transfer Buffer: 5.81 g Tris 
(hydroxymethyl) aminomethane (48 mM), 2.98 g Glycin (39 mM), 0.35 g SDS (1.3 
mM), 200 ml Ethanol (20%). Volume was completed with ddH2O to 1 L, there was 
no need to adjust pH and the final pH is 9.8. Solution 1: 8.85 ml ddH2O, 1 ml Tris 
(hydroxymethyl) aminomethane (1 M, pH 8.5), 100 µl Luminol (250 mM), 40 µl 
Coumaric acid (90 mM). Solution 2: 9 ml ddH2O, 1 ml Tris (hydroxymethyl) 
aminomethane (1 M, pH 8.5), 6 µl H2O2 (30%). 
2.4.11 Gibson Assembly 
GA (Gibson Assembly) is capable of multiple DNA fragments assembly regardless of 
fragment length and end compatibility. Multiple overlapping of DNA fragments can 
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be done in a single tube isothermal reaction. The vector we used for GA was 
pSG1164-NLMV. Genomic DNA of B. subtilis PY79 was used as template, and the 
primers were designed to contain homologous overhangs to the vector. The PCR was 
performed as in Table 4. PCR products were purified with PCR purification Kit 
(Sigma), and the concentration of DNA was measured by Nanodrop or agarose gel 
electrophoresis. 
PCR mixture system PCR program 
Template DNA 1.0 µl 98°C 30 s  
dNTPs (20mM) 1.0 µl 98°C 10 s  
×29 
Forward primer(10µM) 2.5 µl Tm 30 s 
Reverse Primer (10µM) 2.5 µl 72°C 1 min 
HF Buffer (5x) 10 µl 72°C 10 min  
Phusion 0.5 µl 16°C ∞  
ddH2O 32.5 µl    
Table 4. PCR system and program of Gibson Assembly. 
500 ng-1 µg of plasmid pSG1164-NLMV was digested with restriction enzymes ApaI 
and EcoRI-HF. The reaction mixture used was: 500 ng-1 µg plasmid, 5 µl NEB 
Buffer 4, 5 µl BSA (1×), 1.5 µl ApaI, 1.5 µl EcoRI-HF, completed with ddH2O to a 
volume of 50 µl. The mixture was incubated in a thermocycler at 25°C for 1.5 h and 
then at 37°C for another 1.5 h. The digested linear plasmid was purified after 
separation on 1% agarose gel with a gel extraction Kit. DNA was eluted into 30-50 µl 
ddH2O and the concentrations was measured by the Nanodrop. The linear plasmid 
was used for the GA. The GA reaction mixture was as follows: 150 ng plasmid, 50 ng 
insert, 5 µl Gibson Master Mix (2x), completed with ddH2O to 10 µl. The volume of 
plasmid and insert was 5 µl. The final mixture was incubated in a thermocycler at 
50°C for 60 min. Following the incubation, the assembly products were transformed 
into competent E. coli cells and the transformed plasmids were purified, performed 
test digest and sequenced. The success of the procedure and the integration of the 
insert were verfied with a test digest and positive digestion products were sequenced. 
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2.5 Protein overexpression and purification 
2.5.1 Expression test 
The C-terminal of B. subtilis lytC was cloned in pPR-IBA101 (IBA Bio-TAGnology) 
upstream of the One-Strep-tag. The construct was transformed into competent E. coli 
BL21 for protein overexpression. The N-terminal fusion of His-lytC tag was ligated 
with pGAT3 vector downstream of the GST tag. To test if LytC protein was 
successfully expressed by the E. coli host, 4 ml of LB culture with Amp were used for 
the incubation of the desired strain and the culture was incubated on a shaking 
incubator with 200 rpm at 37°C until the OD600 reached a value between 0.5 and 0.8. 
The cells were then induced with 0.5 mM IPTG and further incubated for another 2 h. 
Following the incubation period, 2 ml of cell culture were pelleted down, re-
suspended in 50 µl ddH2O, and mixed with 2×SDS loading dye. The samples were 
then heated at 97°C for 10 min. 15 µl of each sample were loaded into an SDS-PAGE 
gel, and the results were analyzed by western blot membrane. 
2.5.2 Expression and purification of Strep-tagged LytC in E. coli BL21 
The strep-tag purification system is based on the highly selective binding of 
engineered streptavidin, which allows purification of recombinant proteins in vitro 
while preserving their biological activities. This is mainly due to the fact that the 
small size of the strep-tag makes its effects on the tagged protein in terms of structure 
and folding small or even negligible. The E. coli BL21 strain containing the cloned 
construct that was verfied in the above mentioned expression test was inoculated in a 
2 L Erlenmeyer flask containing 1 L LB medium and Amp. Cells were incubated at 
37°C on 150 rpm shaking incubator. When cells reached exponential phase (OD600 
0.5~0.8), they were induced with 0.5 mM IPTG and then moved to 30°C, 150 rpm. 
Cells were harvested after 60 min of incubation by centrifugation for 20 min at 4,500 
rpm, 4°C (BECKMAN COULTER Avanti J-26 XP centrifuge, JLA 9,1000 rotor). 
The pellet was re-suspended in 1×PBS buffer, and then the cells were pelleted down 
again by centrifugation (BECKMAN COULTER Allegra X-15R) at 4,000 rpm, 4°C 
for 20 min. The collected pellet was stored at -80°C or -20°C for further use. On the 
day the experiments were resumed, the pellet was thawed on ice and cells were re-
suspended in 20 ml strep wash buffer with added protease inhibitor (Complete, 
Roche). Cells were then lysed by French-Press by two passes at 20,000 psi, and the 
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lysate was centrifuged at 4°C and 16000 rpm for 30 min (JA-25.50 rotor). The 
supernatant was filtered through a 0.20 µm membrane filter and the filtrate was kept 
on ice for later loading on the affinity chromatography column. PBS Buffer 
(10×Phosphate buffered saline): 16.2 mM Disodium hydrogen phosphate, 50 mM 
Sodium dihydrogen phosphate, 100 mM Sodium chloride. 
Purification of LytC-strep recombinant protein 
Strep-tagged LytC was purified by affinity chromatography using gravity flow 
columns with 1 ml of strep tactin sepharose (IBA). Columns were equilibrated by 
applying 10 CV (column bed volume) strep-tag washing buffer (100 mM Tris HCl, 
150 mM NaCl, 1 mM EDTA, pH 8.0). 0.5 to 10 CV of the clear filtered lysate were 
then loaded on the equilibrated columns. Once all the lysate has passed through the 
columns, unspecific bound proteins were washed away with 10 CV strep-tag washing 
buffer. The column bound strep-tag proteins were then eluted with 3 ml of strep-tag 
elution buffer (100 mM Tris-Hcl, 150 mM NaCl, 1 mM EDTA, 2.5 mM D-
desthiobiotin, pH 8.0) and collected in 0.5 ml fractions. Columns were regenerated by 
15 CV of strep-tag regeneration buffer (100 mM Tris-HCl pH 8.0, 150 mM NaCl, 1 
mM EDTA, 1 mM HABA, hydroxy-azophenyl-benzoic acid), HABA was then 
removed and columns were equilibrated by adding 10 CV washing buffer. The 
columns were then stored at 4°C overlaid with 2 ml washing buffer. All the above 
steps were performed at 4°C, the elution fractions will be analyzed by SDS-PAGE 
and western-blotting and for further analysis. 
2.5.3 Expression and purification of His-tagged LytC in E. coli BL21 
The pGAT3 with the GST-His-LytC N-terminal fusion was cloned in E. coli BL21 
and an expression test was made as described above for the C-terminal fusion. The 
subsequent steps of incubation and lysate preparation were identical to those 
described for the strep-tagged LytC construct. His-tag columns were used for 
purification of Histidine-tagged recombinant proteins by immobilized metal ion 
affinity chromatography (IMAC). The high-performance matrix of the Ni-sepharose 
medium provides a convenient way in protein separation since it has a low nickel 
(Ni2+) ion leakage and is compatible with a wide range of additives used in protein 
purification. His-LytC was purified by IMAC using gravity flow columns with 1 ml 
of Ni-sepharose bed (GE Healthcare). Columns were first washed by at least 5 
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column volumes of distilled water or binding buffer. The filtered lysate was then 
applied to the column, washed with 10-15 CV binding buffer, and finally eluted with 
at least 10 fractions of 0.5 ml elution buffer. Fractions were either stored for further 
usage or immediately used for other experiments. The used columns were stripped by 
washing with at least 5-10 CV of stripping buffer, followed by 5-10 CV of binding 
buffer and 10 CV of distilled water. The stripped column were then recharged by 
loading 0.5 ml of 0.1 M NiSO4 in distilled water, and finally washed with 5 CV 
distilled water and 5 CV binding buffer (to adjust the pH) and stored in 20% ethanol 
at 4°C. Binding buffer: 20 mM sodium phosphate, 0.5 M NaCl, 20 mM imidazole. 
Elution buffer: 20 mM sodium phosphate, 0.5 M NaCl, 500 mM imidazole. Stripping 
buffer: 20 mM sodium phosphate, 0.5 M NaCl, 50 mM EDTA. pH7.4. 
2.5.4 Gel filtration 
Gel filtration chromatography separates proteins on the basis of their sizes. Protein 
molecules pass through a bed of porous beads, enter into the beads. Smaller protein 
molecules enter further into the pores of the beads and thus move slowly to pass 
through the bed, while larger protein molecules enter less or not at all into the pores of 
the beads and therefore move quicker to pass through the bed. Both molecular weight 
and 3-dimensional shape determine the degree of retention. To remove unspecific 
proteins from purified samples, gel filtration was carried out by affinity 
chromatography using an ÄKTApurifier (GE Healthcare) and a gel filtration column 
(Superdex 200 10/300 GL, GE Healthcare). The column was equilibrated with strep-
tag washing buffer prior to loading the protein samples. The column was then flushed 
with the same buffer at a flow rate of 2.0 ml/min at 4°C and the fractionation was 
programmed to collect 30 fractions of 1 ml volume. The fractions were then tested for 
purity by SDS-PAGE and the identity of the protein was confirmed by western-blot. 
2.5.5 Concentration of proteins by Ultrafiltration 
Ultrafiltration was used in order to concentrate proteins by passing the purified 
protein samples through concentrator columns (Sartorius Stedim Biotech, 50 kDa, 30 
kDa, 10 kDa MWCO PES). A total of 6 ml of proteins in buffer were added to the 
columns, followed by centrifugation at 4000 rpm, 4°C until a volume of only 1 ml 
was retained above the filter. 
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2.5.6 Bradford protein assay 
Protein concentration was measured by Bradford with BSA (Bovine Serum Albumin) 
as a standard. Gradient concentrations of BSA (from 2.5-100 µg/ml) and different 
dilutions of tested protein samples were prepared. Protein samples were mixed with 
5×Bradford solution to a volume of 200 µl and then with ddH2O to a final volume of 
1 ml. The mixture was incubated at room temperature for 30 min and the absorption 
of the control containing BSA alone and of protein samples were measured. The 
absorption values of BSA dilutions were plotted against the respective concentration 
and the curve was used to calculate the concentration of desired proteins. 5×Bradford 
Solution composition: 100 mg/l Coomassie Blue, 5% (v/v) Ethanol, 10% (v/v) H3PO4. 
2.6 Fluorescence Microscopy 
The genetically-encoded fluorescent proteins (FPs) were used as reporter dye 
molecules for in vivo fluorescence microscopy imaging, which is a powerful and well 
characterized experimental method for inquiring biological processes in intact cells 
[149]. The naturally green fluorescent protein (GFP) was first discovered in 1962 and 
produced by the marine jellyfish, Aequorea victoria [150]. The natural form of GFP 
has an excitation wavelength of ~395 nm. Cloning of this gene in 1992 was a 
milestone in the laboratory applications of GFP [151, 152]. The successful expression 
of GFP in several foreign hosts (eukaryotes and prokaryotes) demonstrated that for 
the luminescence there is no need for jellyfish specific biological catalysts [153, 154]. 
Controlled mutation of gfp gene by molecular biology can produce brighter, faster 
mature proteins than the natural GFP, mutated GFP can be excited with visible light 
over a wide range of wavelengths [155]. The GFP variant genes can be fused as 
fluorescent tags to unrelated proteins in a foreign organism. The use of the GFP 
family as molecular dyes in living cells has increased tremendously over the last 
decade and became widely used to investigate biological processes [156-158]. The 
GFP tag can be excited and the fluorescence of single molecules visualized in 
functional living organisms with advanced microscopy techniques [159-161]. 
2.6.1 Cell growth and sample preparation 
All B. subtilis and E. coli strains used for fluorescence microscopy were grown at 
30°C in S750 minimal medium, which was complemented with 0.002% casamino 
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acids and necessary antibiotics. For the strains that have a xylose promoter, the 
glucose in S750 was exchanged for 0.5% fructose, and 0.5% xylose was added for 
induction. If the cultures needed to be incubated overnight, it was done at 25°C. The 
cells were then diluted into fresh medium with a ratio of 1:100, and incubated on a 
200 rpm rotary shaker at 30°C until they were ready to use (usually exponential 
phase). 3.5 µl cells were transferred to a glass slide (Roth, Microscope slides standard) 
coated with an agarose layer and then covered with an objective slip (Roth, Cover 
slips). The slide agarose was made by dissolving 1% agar in S750 minimal medium 
(10 mg/ml molecular standard agarose).  
2.6.2 Fluorescence microscopy stains 
The fluorescence microscopy and conventional light microscopy were performed by 
using the Zeiss TIRF microscope with an oil immersion objective (1.45 numerical 
aperture, 100×magnification) and a CCD camera. If necessary, DNA were stained 
with 0.2 ng/ml blue fluorescent dye DAPI (4'6-diamidino-2-phenylidole) in cell 
culture and incubated for 2 min at RT. DAPI preferentially binds AT clusters in the 
minor groove of double stranded DNA and can be used in living cells due to its ability 
to pass through the membrane. DAPI stain was excited with 358 nm wavelength and 
visualized at 460 nm. Cell membranes were stained by FM4-64 (which is a non-toxic 
lipophilic styryl compound) with a final concentration of 2.5 mg/ml and excited at 
515 nm and observed at an emission of 640 nm in the red range. 
2.6.3 Image acquisition 
Fluorescence microscopy images were obtained with the digital camera (EM-CCD 
camera, Photometric Cascade). The microscopy was controlled and recorded with the 
Metamorph 7.5.5.0 program (Molecular Devices, Sunnyvale, USA). The program can 
also be used to calibrate the intensity of fluorescence and specify the cell length 
according to pixel size. The filter setup used was as follows: yellow 475-525 nm 
(excitation wavelength) and 505-565 nm (emission wavelength); red 534-558 nm 
(excitation wavelength) and 575-640 nm (emission wavelength). All fluorescence 
microscopy and bright-field photos were processed by the ImageJ program (by 
Wayne Rasband at National Institutes of Health) with corresponding plugins. 
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2.7 Single molecule microscopy 
Fluorescence microscopy offers a minimally perturbative approach to probe biology 
in vivo, but the traditional techniques are limited in sensitivity and resolution. Many 
biological processes happen on a timescale of milliseconds, and it is hard to study the 
proteins function at single molecule level. A new imaging system that can detect and 
quantify fluorescent proteins at the single molecule level has been developed. In this 
system, the microscopy is customized with a illumination mode called 'slimfield'. The 
excitation intensities of slimfield is ~100 times greater than the wide-field, slimfield is 
also a cheap and simple approach, which allow single-molecule detection at high 
speed [149]. Slimfield facilitates millisecond time scale imaging of single molecule, 
and the time scale is fast enough to catch the diffusional motion and molecular 
transitions in the cytoplasm [162]. 
A laser with appropriate intensity is used to excite the single fluorescent molecule and 
the emitted light is captured by a high-sensitivity video camera [163]. In the 
heterogeneous solvated environment of the living cell, a major task of single-
molecule-microscopy is to reduce the background noise to produce an contrast that is 
sufficient to detect the single-molecule-signal [149]. An optimized low background 
epifluorescence microscopy (LBEFM) is used to visualize the movement of single 
fluorophores [164, 165]. Total internal reflection microscopy (TIRF) is another high-
contrast mode of fluorescence illumination, which can be used with slimfield to 
visualize single fluorescence proteins in or near the membrane [165, 166]. However, 
this method cannot monitor processes occurring in cytoplasm [149]. Other 
illumination modes can be used for imaging the cytoplasm of cells, confocal 
fluorescence microscopy offers a high resolution for functional biological imaging 
[167, 168]. Resolution improvements in deep in vivo can be achieved by using multi-
photon excitation, this technique has been used at single-molecule level to visualize 
organic dye molecules [149, 169]. An expanded illustration of the slimfield mode is 
showen in Figure 7.  
The fluorescence excitation field is reduced to encompass only a single cell in 
slimfield microscopy. Slimfield creates a relatively compact Gaussian laser excitation 
field (~30 µm2) compared to widefield epifluorescence microscopy. The fluorescence 
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emission intensity is then higher than the readout and dark noise of the camera 
detector, which suitable for single-molecule detection and with high signal intensity 
[149, 170]. In the excited area, most of the fluorescence protein signals are fast 
bleached until only a few non-bleached molecules are left to be tracked. A stream of 
images is be captured by the camera to record the trajectory of single molecules. 
 
Figure 7. Cartoon depicts the excitation modes of confocal and slimfield. A is the 
conventional confocal microscopy, B is the slimfield illumination mode. Image taken from 
the work of Michael Plank, 2009 [149]. 
2.7.1 Sample preparation for single molecule microscopy 
The objective slips were washed ultrasonically cleaned in 2% Hellmanex III solution 
for 10 min and subsequently dried by Elix Clean 720 GAS, then 3.5 µl fresh cell 
culture were transferred onto the slide and covered with an agar-pad (1% high 
molecular grade agar dissolved in S750).  
2.7.2 Single molecule microscopy 
Single molecule microscopy was performed in order to gain insights on proteins 
dynamic and movement in living B. subtilis cells. All the proteins were tagged with a 
yellow fluorescent protein (YFP). Cells were imaged with a NIKON microscope 
equipped with a back-illuminated EM-CCD camera and modified to have a slimfield 
setup. The objective used has a 1.45 light aperture. The excitation laser was focused 
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onto the back focal plane of the objective to increase the illumination, 10 mW of laser 
power were used at the sample plane within a square of 25×25 µm and the time 
interval used was 10 ms. The intensity of fluorescence in the stream decreased from 
the center of the imaged area to the edges and the number of single molecules 
dropped with time because of bleaching. The movies were between 1000 and 5000 
frames long. If not mentioned otherwise, all the constructs in B. subtilis used for 
single molecule microscopy were expressed under the xylose promoter. 
2.7.3 Single molecule tracking and track analysis 
The tracking analysis of single molecule data was done with plugins of 
MTrackJ/TrackMate on ImageJ, or by u-track-2.3.1 that was specifically written for 
MatLab. The obtained tracking data were analyzed by msd-analyzer in MatLab. Only 
the desired area of the recorded movies was cropped and the format was converted 
from RAW to TIFF through ImageJ. Trajectories that consist more than 5 frames 
were considered as a track and be used for further analysis. 
2.7.4 Calculation of the diffusion constants (diffusion coefficient) by MSD 
Mean square displacement (MSD) analysis is a commonly used technique in 
biophysics study to determine the displacement mode (freely diffusing, transported, 
bound) of particles over time. And MSD analysis can also help to determine the 
diffusion coefficient of the particles movement. Msd-analyzer is a MATLAB tool that 
use for performing MSD analysis. The plot of MSD value can describe the diffusing 
movement of the particle. The MSD was calculated for each individual trajectory, and 
its log-log representation was fitted with a linear function. The slope of MSD line 
gives us the diffusion coefficient. The MSD for each single particle is also taken as a 
mean value. By default, the fit is only made on the first 25% of the curve and 
automatically calculated by msd-analyzer.  
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3 Results 
3.1 Inhibition study of different constructs of protein LytC in vitro 
3.1.1 Design of lytC gene constructs 
C-terminal strep-tag fusion of lytC constructs were cloned into pPR-IBA101 vector 
and further expressed in E. coli BL21(DE3) cells. The products of each recombinant 
fusion protein were measured by SDS-PAGE and immunoblot analysis. We predicted 
LytC structure with the SMART tool from Heidelberg University. The predicted LytC 
protein structure has a trans-membrane domain at the N-terminus (a.a. 7-24). Since 
we need to purify LytC in a soluble state, therefore, we removed the trans-membrane 
domain. In the middle of LytC, there is one low-complexity-region (LCR, a.a. 197-
214) and three cell-wall-binding (CWB) domains. The functional region (a.a. 380-492) 
of catalytic domain is located at the C-terminus of LytC. In order to narrow down the 
N-terminal region that is important for lyse activity of LytC, regions in front of 
functional region were truncated into fragments of decreasing length and the lyse 
activity was measured respectively. To study the roles of these domains in LytC, we 
designed 6 constructs (Figure 8).  
 
Figure 8. Schematic of LytC structure and lytC constructs. The rectangle stands for the trans-
membrane domain, we removed this part since we want to purify soluble proteins. The round 
circle is the functional domain that catalyzes the cleavage of cell wall component PG. The 
small purple rectangle represents cell-wall-binding domains in LytC protein, which help LytC 
to bind with cell wall. The small green rectangle is the low-complexity-region. F1-F6 are the 
forward primers (I named each of my constructs by lytC+forward primer, e.g. lytCF2 means 
the construct with F2 as forward primer, all the constructs have the same reverse primer), the 
black arrows stand for the start sites of each primer.  
Table below is a brief summary of all the LytC constructs and feedback. The detail of 
each construct and the inhibition test results were displayed in the following chapters. 
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Name Primers Domains Results 
LytCF1 LytCEcoRIF1/LytC
XhoIR 
Two CWB, the LCR 
and the FR. 
Purification failed. 
LytCF2 LytCEcoRIF2/LytC
XhoIR 
One CWB and the full 
length of FR. 
Inhibition tests on E. coli and B. 
subtilis were positive (Figure 15). 
LytCF2R2 LytCEcoRIF2/lytc 
xhoi R2 
One CWB and 22 a.a. 
deleted FR. 
Inhibition tests on E. coli and B. 
subtilis were positive but the 
activity was much lower than 
LytCF2 (Figure 24). 
LytCF3 LytCSacIIF3/LytC
XhoIR 
Half LCR, one CWB 
and the FR. 
Inhibition test on E. coli was 
positive (Figure 15 D). 
LytCF4 LytCSacIIF4/LytC
XhoIR 
Three CWB, the LCR 
and the FR. 
Inhibition test on E. coli was 
positive (Figure 16 A). 
LytCF5 LytCSacIIF5/LytC
XhoIR 
Region after CWB and 
FR. 
Inhibition tests on E. coli and B. 
subtilis were positive (Figure 17 
and Figure 18). 
LytCF5-
E342Q 
lytcE342F/lytcE342
R 
Region after CWB with 
E342Q mutation. 
Inhibition tests on E. coli and B. 
subtilis were positive (Figure 22). 
LytCF5-
E461Q 
lytcE461F/lytcE461
R 
Region after CWB with 
E461Q mutation. 
Inhibition tests on E. coli and B. 
subtilis were positive (Figure 22). 
LytCF5-
E342Q-
E461Q 
LytCecoriCF/LytCx
hoiCR 
Region after CWB with 
E342Q and E461Q 
mutation. 
Inhibition test on E. coli was 
positive (Figure 23). 
LytCF6 LytCEcoRIF6/LytC
XhoIR 
The FR domain. Inhibition test on E. coli was 
positive (Figure 16 B). 
GST-His-
LytCF1 
GST-F1/GST-R Same as LytCF1 Purification failed. 
GST-His-
LytCF2 
GST- F2/GST-R Same as LytCF2 Purification failed. 
GST-His-
LytCF3 
GST- F3/GST-R Same as LytCF3 Purification failed. 
GST-His-
LytCF4 
GST- F4/GST-R Same as LytCF4 Purification failed. 
GST-His-
LytCF5 
GST- F5/GST-R Same as LytCF5 Purification failed. 
GST-His-
LytCF6 
GST- F6/GST-R Same as LytCF6 Inhibition test on E. coli was 
positive (Figure 16 C), but the 
activity was much lower than 
LytCF6. 
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Table 5. Summary of lytC constructs and the inhibition results. The trans-membrane domain 
was removed in all lytC constructs. LytC remains the catalytic activity as long as the full 
length of FR kept. Two amino acids mutation in FR domain does not reduce the activity of 
LytC, which means E342 and E461 amino acids are not important for LytC. 22 amino acids 
deletion of C-terminus of FR domain can reduce the lyse activity of LytC greatly, indicating 
that LytCF2 contains the full length of FR and the FR domain remains the lyse activity. All 
the LytC constructs without His label were fused to strep-tag at the C-terminus. CWB: cell-
wall-binding domain. LCR: low-complexity-region. FR: functional region. 
3.1.2 Purification of constructed protein LytCF2 
E. coli cells with recombinant proteins were pelleted down by centrifugation, and 
further lysed by French-Press. The supernatants that contain the recombinant proteins 
were purified through affinity chromatography strep-tactin columns. The expression 
and purification of each LytC constructs was confirmed by SDS-PAGE and 
Immunoblot analysis. In the Immunoblot analysis, the band that corresponds to the 
strep-tagged proteins should be detected according to the corresponding molecular 
weight (MW). Before the purification of LytC, test overexpression of each construct 
was confirmed by SDS-PAGE and western-blot. Since LytCF2 is the first positive 
construct we obtained, we chose LytCF2 for the selection of host strain and the 
optimization of growth condition. The selected host strain, growth condition were 
used for the remaining LytC protein overexpression. 
LytC kills host E. coli strain during overexpression step 
During the incubation process of protein overexpression, we found that LytCF2 is 
toxic and can inhibit the growth of E. coli BL21 cells. After inducing with 0.5 mM 
IPTG, the OD600 of E. coli dropped dramatically within 1 hour (e.g. from 0.7 to 0.33) 
(Figure 9). However, if the cells were induced with 1 mM IPTG, the cells grew 
normally (data not shown). We used both 0.5 mM IPTG and 1 mM IPTG for LytCF2 
overexpression and purification. According to the SDS-PAGE staining and followed 
immunoblot analysis, much less protein was obtained from the culture induced with 1 
mM IPTG than the one with 0.5 mM IPTG (data not showed), thus we used 0.5 mM 
IPTG for the remaining experiments. 
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Figure 9. Growth curve of BL21 during LytCF2 overexpression, culture were induced with 
0.5 mM IPTG. The time interval is 40 min. In all three times experiments, we observed the 
OD600 start to drop after 1 hour incubation. For the 2nd experiment, the OD600 continue 
increasing in 40 min but dropped in 1 hour after induction. 1st, the first experiment. 2nd, the 
second experiment. 3rd, the third experiment. 
The optimization of host strain and growth condition 
At the beginning, we used E. coli BL21 (DE3) and Rosetta 2 (DE3) for the test 
overexpression of LytCF2. After cells lysed, the remaining LytCF2 in Rosetta pellet 
was much larger than the BL21 pellet (Figure 10 C). Therefore, BL21 was used as 
host for the remaining LytC protein overexpression experiments. LytCF2 has a 
molecular weight of around 36 kDa, the purity of purified LytCF2 was tested by SDS-
PAGE and western-blot (Figure 10 A and B). The bigger bands (the white ellipses of 
Figure 10 A) above LytCF2 were confirmed to be chaperones by MS-SPEC 
measurement. The bands that smaller than LytCF2 band might be the un-correct 
folded or lysed protein. The expression level of LytCF2 did not fulfill our expectation, 
and the low temperature overexpression is usually used for low expression protein. 
Therefore we perform the low temperature overexpression for LytCF2. However, 
production level of low temperature was not increased in comparison with 30°C 
overexpression (data not shown). Thereby, overexpression of all LytC proteins were 
performed at 30°C. 
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Figure 10. SDS-PAGE and western-blot results of purified LytCF2. (A): The SDS-PAGE 
image of purified LytCF2, lanes 1, 2 and 3 stand for different fractions of LytCF2 after 
purification by strep-tactin column, lane 4 represents prestained protein ladder (NEB). (B) 
Western-blot image: 1 is protein ladder, 2, 3, 4, 5 and 6 are different fractions of purified 
LytCF2. (C) Western-blot image: 1 is the BL21 pellet after cell lysis, 2 is the purified LytCF2 
with BL21 as host, 3 is prestained protein ladder, 4 is the pellet after cell lysis using Rosetta 
2(DE3) as host, 5 and 6 are two fractions of purified LytCF2 using Rosetta 2(DE3) as host. 
The black arrows and the black ellipse show the position of strep-tagged LytCF2, the white 
ellipse shows the bands of chaperones. Strep antibody was used in the western-blot detection. 
Protein purification of other LytC constructs. 
After we purified the LytCF2 construct protein successfully, we tried to purify the 
construct of LytCF1 protein (a.a. 31-496, 50 kDa). Unfortunately, the purification of 
LytCF1 protein was not successful. We cannot detect LytCF1 in the strep elution 
fractions but in the cell pellet (Figure 11 D). LytCF3 (a.a. 210-496) has a molecular 
weight of about 32 kDa. The LytCF3 protein was first purified by affinity 
chromatography using strep-tactin column, yet the purity degree was too low. 
Therefore, a further purification step by gel filtration is necessary. After the gel 
filtration, the purity of LytCF3 protein increased even though a impurity band at 55 
kDa remains with LytCF3. The impurity band turned out to be a chaperone of LytC 
by MS-SPEC analysis (Figure 11 A, B and C). 
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Figure 11. LytCF1 and purified LytCF3. (A) SDS-PAGE image of purified LytCF3. (B) 
Western-blot image of purified LytCF3 (strep antibody was used). Double head black arrow 
shows the position of LytCF3. Lanes 1, 2, 4, 5 and 6 are the different fractions of purified 
LytCF3, lane 3 is the prestained protein ladder (NEB), lane 7 is the cell pellet after lysis. (C) 
SDS-PAGE image of LytCF3 after gel filtration. Lane 1 is the prestained protein ladder, lane 
2 to 5 are different elution fractions of gel filtration. Black arrow shows the position of 
LytCF3. (D) Western-blot image of LytCF1, lane 2 represents the supernatant after cell lysis, 
lane 3 stands for prestained protein ladder, lane 4 represents the pellet after cell lysis, lane 1 
stands for the elution fraction of purified LytCF1. Black arrow shows the position of LytCF1. 
LytCF4 (a.a. 25-496) and LytCF6 (a.a. 377-496) have a molecular weight of 57 kDa 
and 10 kDa, respectively. The purity of purified LytCF4 and LytCF6 were detected by 
SDS-PAGE and Western-blot (Figure 12). LytCF6 was concentrated with 
ultrafiltration columns, LytCF6 can be concentrated with 30 and 50 kDa MWCO PES 
columns with a molecular weight of 10 kDa. This phenomenon proves that LytC is 
not a monomeric protein. 
LytCF5 (a.a. 319-496) has a molecular weight of about 25 kDa. A test overexpression 
was performed before the purification of LytCF5. LytCF5 was first purified by strep 
column and second by gel filtration, we obtained pure LytCF5 after the two steps of 
purification (Figure 13 C). there is a undesired band of around 50 kDa after the first 
strep purification (Figure 13 A and B) but this band was removed after the second gel 
filtration. The purified LytCF5 was concentrated by ultrafiltration (Sartorius Stedim 
Biotech) with concentrator columns, I discovered that LytCF5 can be concentrated 
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with 30 and 50 kDa MWCO PES columns even though LytCF5 has a molecular 
weight of 25 kDa. This phenomenon indicates that LytCF5 is not a monomer.  
We also tried to produce an N-terminal fusion of GST-His tagged LytC with the same 
construct regions as the Strep-tag. Unfortunately, none of the fusion (From GST-His-
LytCF1 to GST-His-LytCF5) worked except for GST-His-LytCF6, and the purified 
GST-His-LytCF6 is shown in Figure 14. 
 
Figure 12. Purified LytCF4 and LytCF6. (A) SDS-PAGE image of purified LytCF4. (B) 
Western-blot image of purified LytCF4. In A and B, black arrow shows the position of 
LytCF4 Lanes 1, 2, 3, 5, 6 and 7 are the different elution fractions of purified LytCF4, lane 4 
is the prestained protein ladder (NEB). The black arrows show the position of LytCF4 on 
SDS-PAGE and Western-blot images. C and D are the SDS-PAGE and Western-blot images 
of LytCF6. In C and D, lane 1 stands for prestained protein ladder (Thermo), lanes 2-6 are 
different elution fractions of purified LytCF6 products. The black arrows of C and D show the 
position of the LytCF6 protein. Strep antibody was used in immunoblot experiments. 
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Figure 13. Purified LytCF5. (A) SDS-PAGE of purified LytCF5. Lane 1 represents prestained 
protein ladder (NEB), 2-7 are different fractions of purified products. (B) Western-blot image 
of purified LytCF5. Lane 3 is protein ladder (NEB), lane 1, 2, 4, 5, 6, 7 are different fractions 
of purified products. (C) SDS-PAGE of LytCF5 after gel filtration. Lane 1 is prestained 
protein ladder (Thermo), 2 and 3 are examples of 2 purified fractions. The black arrow shows 
the position of LytCF5. 
 
Figure 14. Purified GST-His-LytCF6. (A) SDS-PAGE image of purified GST-His-LytCF6. 
Lane 1 represents prestained protein ladder (Thermo), lanes 2, 3 and 4, represent different 
elution fractions of purified His-tag products; (B) SDS-PAGE image of purified GST-His-
LytCF6. Lane 1 represents protein ladder, lanes 2, 3 and 4 represent different elution fractions 
of purified His-tag products. The black arrows show the position of GST-His-LytCF6 in 
images, the GST tag is 25 kDa, so the fused LytCF6 is around 39 kDa. 
3.1.3 The functional study of constructed LytC proteins 
LytC inhibits the growth of bacteria in liquid culture 
In our study, we first found that LytCF2 can inhibit the growth of E. coli XL1 and 
BL21 with a final concentration of as little as 7.6 mM. Overnight incubated E. coli 
and B. subtilis cultures were inoculated into fresh LB medium containing strep elution 
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buffer or purified LytCF2 protein. The OD600 of E. coli was measured after 3 and 5 
hours of incubation, and the OD600 of B. subtilis was measured after 2, 3, 5 and 6 
hours of incubation. The growth difference between the control and samples started to 
appear after 3 hours incubation (Figure 15). With a concentration of 17 mM, LytCF2 
inhibited the growth of B. subtilis, the growth difference between the control and 
treated samples was subtle after 2 hours of incubation. After incubated for 3 hours, 
the difference could be observed and increased strongly with time and the treated 
sample also grew but much slower in comparison with the control (Figure 15 C). To 
test the stability of LytCF2, LytCF2 stored at room temperature (over 24 hours), 4°C 
(over one week), -20°C and -80°C were used to treat E. coli and B. subtilis. The 
activity of LytC was mostly kept in comparison with the fresh LytCF2, so LytCF2 is 
relatively stable (data not shown). For test the inhibition effect, the purified LytCF3 
after gel filtration was used to treat E. coli. An overnight culture was inoculated into 
500 µl fresh LB rich medium, the control was treated with 150 µl strep elution buffer 
and the test samples were treated with 150 µl purified LytCF3. LytCF3 produces a 
strong inhibition on the growth of E. coli after 3 hours of incubation (Figure 15 D). I 
chose E. coli BL21 as object to test the inhibition ability of LytCF4. My results 
showed that LytCF4 is able to inhibit the growth of BL21 ( Figure 16 A) with a final 
concentration of 10.2 mM. The concentration of LytCF4 that needed to degrade cell 
wall is higher than other constructs, the reason could be because there is a high 
amount of chaperone proteins in the purified LytCF4 and the actual concentration 
should be much lower. E. coli XL1 and BL21 were used to test the inhibition activity 
of LytCF6. The results showed LytCF6 inhibits the growth of E. coli, which means 
that LytC can function as bacteria growth inhibitor as long as the functional region 
remained (Figure 16 B). I also further concluded that the deletion of CWB and LCR 
will not cause the activity lost of LytC, the same applies to the trans-membrane region. 
Treatment of bacteria with GST-His-LytCF6 showed that the fused protein has a 
minor effect on the growth of E. coli and no effect on B. subtilis (Figure 16 C), the 
reason could be that the N-terminal fusion or the GST-His affected the correct folding 
of LytC and therefore inhibited the activity of LytC. My results showed that LytC 
cannot maintain the function with His-tag fused at its N-terminal. 
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Figure 15. LytCF2 inhibits the growth of Gram-negative bacteria E. coli (A and B) and Gram-
positive bacteria B. subtilis (C). In A and B, the final concentration of LytCF2 was 7.6 mM. 
In C, the final concentration of LytCF2 was 17 mM. (D) LytCF3 inhibits the growth of E. coli 
with a final concentration of 3.1 mM. Control was treated with strep elution buffer.  
 
Figure 16. (A) LytCF4 inhibits the growth of E. coli BL21. (B) LytCF6 inhibits the growth of 
E. coli with a final concentration of 1.3 mM. (C) E. coli treated with GST-His-LytCF6, which 
has a final concentration of 1.8 mM.  
To test the inhibition activity of LytCF5 in E. coli and B. subtilis, 500 µl cultures 
were used to be treated with different volumes of LytCF5. Two LytCF5 samples were 
used in this experiment, both were frozen in -80°C before used. One sample was 
frozen (-80°C) and melted twice, which has a concentration of 125 mM. The other 
sample was frozen (-80°C) and melted only once, which has a concentration of 87 
mM. The test results are shown in Figure 17 B, the activity of LytF5 was lost after 
two times of freeze and melt, even though the final concentration of the twice frozen 
sample (20.8 mM for the one that treated with 100 µl LytCF5) is higher than the once 
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frozen sample (14.5 mM for the one that treated with 100 µl LytCF5). We concluded 
that the activity of LytCF5 should be partially kept with once frozen, but twice frozen 
will destroy the structure of LytCF5, which cause the activity lost. Therefore, LytCF5 
is moderate stable. The results of LytCF5 inhibits the growth of E. coli are shown in 
Figure 17 A, C and D. From Figure 17 A, when the concentration of LytCF5 reaches 
4.8 mM (final concentration), it can inhibits the growth of E. coli efficiently. The 
second experiment confirmed (Figure 17 C and D) that LytCF5 inhibits the growth of 
E. coli. We noticed that the OD600 of control (from X axis 2, 3.7 to 6.3 mM) also 
decreased with increased strep elution buffer, the reason could be the salts in elution 
buffer can inhibit the growth of bacteria. The control of 6.3 mM LytCF5 (200 µl) was 
added more elution buffer than the control of 3.7 mM LytCF5 (100 µl) and 2 mM 
LytCF5 (50 µl).  
 
  
Figure 17. (A) LytCF5 inhibits the growth of E. coli. The black bars stand for XL1-Blue 
treated with strep elution buffer as a control. The white bars represent XL1-Blue treated with 
different concentrations of LytCF5. (B) LytCF5 inhibits the growth of B. subtilis PY79. The 
black bars stand for PY79 treated with elution buffer as control,. The lattice bars stand for 
PY79 treated with twice frozen LytCF5 (125 mM). The white bars stand for PY79 treated 
with once frozen LytCF5 (87 mM). All the original cultures were 500 µl. C and D are 
confirmation of LytCF5 inhibits the growth of E. coli. (C) Gradient concentration test of 
LytCF5 on XL1-Blue. (D) Gradient concentration test of LytCF5 on BL21. LytCF5 can 
greatly inhibit the growth of E. coli when the final concentration of LytCF5 reaches 2 mM. 
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LytCF5 inhibits the growth of E. coli and B. subtilis with time course was observed. I 
recorded the OD600 after 3 hours of incubation for E. coli and 1 hour incubation for B. 
subtilis. For E. coli, the control grew normally while the treated sample stayed the 
same. BL21 treated sample started to grow slowly after 5 hours of incubation. The 
reason could be the catalytic activity of LytCF5 exhausted after lysis the cell wall for 
5 hours. For B. subtilis, the control grew much faster than the treated sample, which 
started to grow after 3 hours of incubation but very slowly. We suppose the reason 
could be that B. subtilis has thicker PG layer than E. coli so the activity of LytCF5 for 
B. subtilis exhausted faster than the one of E. coli even with a higher concentration of 
LytCF5. 
 
Figure 18. Time course of LytCF5 inhibiting the growth of E. coli and B. subtilis. In images 
A and B, the final concentration of LytCF5 was 3.7 mM, for image C the final concentration 
of LytCF5 was 8.3 mM. The black bar (A) represents XL1 cells treated with strep elution 
buffer as control. The empty white bar (A) represents XL1 cells treated with LytCF5. In B, 
the black circle represents control of BL21 cells treated with strep elution buffer, the empty 
white triangle represents BL21 treated with LytCF5. In C, the black circle represents PY79 
cells control that treated with strep elution buffer, the empty white triangle represents PY79 
cells treated with LytCF5. 
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LytC inhibits the growth of bacteria on agar plate 
LytCF2 can also inhibit the growth of B. subtilis and E. coli on agar plates (Figure 19 
A, B and C). LytCF2 has the best inhibition effect on XL1, followed by BL21 and 
PY79. The reason that LytCF2 has weak inhibition on PY79 could be because B. 
subtilis grows slower than E. coli, and the LytCF2 might more easily be degraded by 
the secreted protease and the Gram-positive B. subtilis has thicker peptidoglycan than 
the Gram-negative E. coli. I wanted to figure out if LytCF3 can also inhibit the 
growth of B. subtilis on agar plate by applying LytCF3 on agar plate. When PY79 was 
treated with LytCF3 a big degradation halo was formed while the control that treated 
with elution buffer did not form the degradation halo (Figure 19 D). 
 
Figure 19. LytCF2 and LytCF3 inhibit the growth of bacteria on agar plates. (A) LytCF2 
inhibits the growth of XL1-Blue. (B) LytCF2 inhibits the growth of BL21. (C) LytCF2 
inhibits the growth of PY79. (D) LytCF3 inhibits the growth of PY79 on agar plate. 
Autolysin effect rather than the protein effect of LytC inhibits the growth of 
bacteria 
To elucidate if the inhibition of bacteria growth is because of LytC activity or just the 
effect of common protein. We designed another experiment which used bovine serum 
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albumin (BSA) as control to compare with the one in which elution buffer was used, 
and the samples were treated with LytCF3. We performed the experiment of E. coli 
treated with BSA as control to see if other proteins can also inhibit the growth of 
bacteria when dissolved in elution buffer. Our results showed LytCF3 indeed inhibits 
the growth of E. coli while BSA does not, and an interesting phenomenon is that BSA 
can even promote the growth of E. coli (Figure 20 A). The experiment of using 
LytCF5 to treat E. coli (Figure 20 B) also showed that BSA does not inhibit the 
growth of E. coli so we conclude that the LytCF5 is responsible for the growth 
inhibition. E. coli might use BSA as source of protein nutrition which promotes the 
growth. Hereby we can conclude that the E. coli growth inhibition is not the effect of 
common proteins but the specifically of the cell wall breakdown protein LytC.  
  
Figure 20. BSA does not inhibits the growth of E. coli. (A) The final concentration of BSA is 
0.5 mg/ml, and LytCF3 is 6.6 mM. The grey bars represent the E. coli control that treated 
with strep elution buffer. The black bars stand for the E. coli treated with BSA, which was 
dissolved in strep elution buffer. The empty bars stand for E. coli treated with LytCF3. (B) 
BSA (with a final concentration of 5 mg/ml) was dissolved in strep elution buffer. The final 
concentration of LytCF5 was 1.8 mM. The black bars represent control cells treated with 
elution buffer. The lattice bar represent control cells were treated with BSA. The empty white 
bars represent cells were treated with LytCF5. All the original cultures were 500 µl. 
3.2 Site directed mutagenesis of LytC and functional region partial 
deletion  
3.2.1 Site directed mutagenesis 
To test if the inhibition activity was caused by the functional region of LytC, or just 
any region of LytC can lyse the cell wall. I chose LytCF5 as control to perform a site-
directed mutagenesis. From the former work I found two amino acid sites that could 
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be the key sites for the activity of LytC (a.a. 342 and 461) [171]. LytCF5 mutants 
have the same molecular weight as LytCF5. The purified LytCF5 mutants are shown 
in Figure 21. 
 
Figure 21. Images of mutated LytCF5. (A) SDS-PAGE image of LytCF5-E342Q, lane 1 
represents prestained protein ladder (Thermo), lanes 2-6 represent different strep elution 
fractions of purified LytCF5-E342Q. (B) SDS-PAGE image of LytCF5-E461Q, lane 2 
represents the protein ladder, lanes 1, 3, 4, 5 and 6 stand for elution fractions of purified 
LytCF5-E461Q. (C) SDS-PAGE image of LytCF5-E342Q-E461Q. Lane 1 represents the 
protein ladder, 2-7 are fractions of purified LytCF5-E342Q-E461Q. (D) Western-blot (with 
strep antibody) image of LytCF5-E342Q-E461Q, lane 1 represents the protein ladder, lanes 2 
and 3 are LytCF5 double mutation products. Black arrows show the position of purified 
LytCF5 mutant proteins. 
After the construction of LytC single mutants (E342Q or E461Q), the inhibition 
activities of LytCF5 mutants were tested. E. coli cultures were treated with 30 µl of 
purified proteins and B. subtilis cultures were treated with 100 µl of purified proteins. 
The inhibition activity test showed no significant difference between the mutants and 
LytCF5 (Figure 22), the site mutagenesis does not affect the activity of LytC. The 
reason is probably the mutation sites are not the key sites for the function of LytC. 
Since the activity of LytCF5 (E342Q or E461Q) single mutants were not reduced in 
comparison with LytCF5. We constructed the double mutant LytCF5 (E342Q and 
E461Q). And the inhibition ability was tested. The double mutation also did not affect 
the activity of LytC, therefore, the mutation sites are not the key sites for the activity 
of LytC. 
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Figure 22. The inhibition test of LytCF5 single mutants (E342Q or E461Q). The final 
concentration of proteins was 2 mM. The treating object of A was E. coli XL1, B was E. coli 
BL21, C was B. subtilis PY79. The black bar represents control cells that were treated with 
strep elution buffer. The lattice bars represent cells that treated with LytCF5. The bar with 
lines inside represents cells that were treated with LytCF5 (E342Q). The empty white bar 
represents cells that were treated with LytC (E461Q). 
 
Figure 23. The inhibition ability test of LytCF5 double mutant. The final concentration was 
1.8 mM. The black bars were E. coli control that treated with strep elution buffer, the lattice 
bars were treated with LytCF5 and the empty white bars were treated with LytCF5 (E342Q 
and E461Q) double mutants. All culture were treated with 300 µl of sample. 
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3.2.2 Partial deletion of the functional region 
The site-directed mutagenesis did not reduce the activity of LytCF5. Therefore, we 
performed another experiment in which we deleted 22 amino acids at the C-terminal 
of the functional region of LytC. LytCF2R2 (a.a. 220-470) has a molecular weight of 
about 34 kDa. The purified LytCF2R2 is shown in Figure 24 D and E. After we 
purified the partially deleted LytCF2R2, it was used to treat E. coli and B. subtilis to 
check if the lyse activity was lost. Data showed that the activity of LytCF2R2 was 
partially kept but dropped dramatically if compared to native LytCF2 (Figure 24 A, B 
and C). Hereby we confirmed the inhibition activity was from the functional region of 
LytC. 
 
Figure 24. (A, B and C): all the original cultures were 500 µl, treated with 150 µl samples. 
The final concentration of both LytCF2 and LytCF2R2 was 11 mM. The black bars were 
control that cells treated with strep elution buffer. The empty bars represent cells treated with 
LytCF2 while the grey bars represent cells treated with partially deleted LytCF2R2. E. coli 
BL21 was used in A, E. coli XL1 was used in B, B. subtilis PY79 was used in C. (D and E): 
purified LytCF2R2. (D) SDS-PAGE image of purified LytC proteins. (E) Western-blot image 
(with strep antibody) of purified LytC proteins. Lane 1 represents prestained protein ladder 
(Thermo), 2 and 4 were loaded with 1 µl sample, 3 and 5 were loaded 5 µl sample, 2 and 3 
represent LytCF2, 4 and 5 represent LytCF2R2. The black arrows show the position of 
desired proteins. 
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3.3 Microscopy evidence that LytC degrades the cell wall 
To provide further evidence that LytC is capable of degrading the cell wall and thus 
inhibits the growth of E. coli and B. subtilis, we performed microscopy experiments 
after bacteria were treated with LytC. We chose LytCF5 to treat cells for microscopy 
evaluation because the inhibition results by using LytCF5 have been repeated several 
times and the purity of LytCF5 is the highest among all the constructs we made, 
which makes LytCF5 construct the most useful for potential industrial application.  
Microscopy data showed that LytCF5 indeed inhibited the growth of E. coli and B. 
subtilis and further broke down the cell wall (Figure 25). The cell wall of XL1 can be 
lysed by LytCF5, and some cells lost their rod shape and acquired a spherical cell 
shape because of the lysed cell wall (Figure 25 C1 and D1). The cell wall of BL21 
can be lysed and part of cells lost the rod cell shape and acquired the spherical cell 
shape (Figure 25 C2 and D2). LytCF5 also can cause Gram-positive bacteria B. 
subtilis (PY79) to lose the rod cell shape because of cell wall lysis. Since Gram-
positive bacteria PY79 and has thicker cell wall than the Gram-negative E. coli, the 
lysed PY79 were not as widely visualized as E. coli (Figure 25 F and H). 
The same phenomenon was observed when we imaged the E. coli and B. subtilis that 
treated with purified LytCF6 (data not shown). Therefore, we confirmed that LytC 
can hydrolyze cell wall at microscopy single cell level. The attempt to track the 
process of bacterial cell wall breakdown and cell death under live time high resolution 
microscopy was not successful. 
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Figure 25. LytCF5 degrades the cell wall of Gram-negative E. coli (XL1-Blue and BL21) and 
Gram-positive bacteria B. subtilis (PY79) in their exponential growth, and B. subtilis cells 
grow as chains in their exponential growth. A and B are images of E. coli control that were 
treated with strep elution buffer, C and D are images after E. coli cells were treated by 
LytCF5. The white arrows in C1 and D1 show the example of lysed XL1 cells, the black 
arrow in C1 shows that XL1 cells lost the rod cell shape and acquired the spherical cell shape 
because of the lysed cell wall. The white arrows in C2 and D2 show the lysed BL21 cells and 
spherical cell shaped BL21. E and F are images of B. subtilis control; in G and H, PY79 cells 
were treated with LytCF5. White arrows show the lysed PY79. A, C, E and G are bright-field 
images, B, D, F and H are membrane stained images. The white bar is 2 µm.  
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3.4 Localization studies of MreB, MreC, MreD, PfkA, Pbp1A, RodZ 
and subunits of PDH complex in vivo 
3.4.1 Localization studies of MreB, MreC and MreD in vivo 
In order to characterize the structure of MreB in vivo, a yfp-mreB fusion was 
integrated into the chromosomal of B. subtilis by a double cross-over with amyE gene. 
The correct transformants were first selected via Spec resistance, then screened by 
detecting for defective amyE and lack of starch degradation ability. B. subtilis 
transformants were streaked on LB agar plates with 0.5% (w/v) starch and incubated 
overnight in a 30°C incubator. The starch plates were stained with Lugol's iodine 
(solution of iodine and potassium iodide) to screen the colonies with stained halos 
(the negative colonies contain the no-stained halos). The colonies that have stained 
halos are positive transformants, in which the fusion genes were correctly integrated 
into the amyE site of the genomic chromosome. Fusions that were constructed into the 
pSG1164-NLMV and pHJDS vectors were used for the integration of genes into the 
original gene locus with a single cross-over in the B. subtilis chromosome. 
B. subtilis and E. coli grown to exponential phase were used for the imaging of 
functional MreB. Fluorescently tagged YFP-MreB was visualized in B. subtilis. The 
fusion was integrated into the amyE gene locus under the xylose promoter as an 
additional copy to the native MreB from the original gene locus [92]. In order to 
further investigate the function and structure of MreB, the comparison of MreB 
localization in B. subtilis and E. coli strains were performed. We obtained two E. coli 
strains (kindly gifts from the laboratory of Jan Löwe, Cambridge, UK) with GFP-
MreB, both were used to visualize the localization of MreB in E. coli. In one strain 
(PG3087), GFP-MreB was integrated into the chromosome of E. coli, in another 
strain (PG3088), GFP-MreB was cloned into pS2131 vector and transformed into E. 
coli. In both strains, GFP-MreB was under control of the T7 promoter. Only the 
localization results of GFP-MreB that was integrated into the chromosome of E. coli 
will be presented, because from both E. coli strains the localization patterns of GFP-
MreB were the same. The attempt to perform single molecule microscopy of GFP-
MreB in E. coli failed, since MreB is a high-copy protein. We could not manage to 
get single molecule level of MreB in E. coli even though the amount of IPTG we used 
in this study was under strict control. We tried gradient concentrations of IPTG for the 
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GFP-MreB E. coli strain, however, we either have over expressed MreB or weak 
illumination signal of GFP-MreB that was not strong enough to recognize the single 
molecules. 
MreB filaments in B. subtilis localized as discontinuous filamentous structures that 
are located underneath the cell membrane (Figure 26 A), the same phenomenon was 
observed in E. coli (Figure 26 D). With the reduction of xylose induction, YFP-MreB 
localized in B. subtilis as a patchy structure (Figure 26 B). If we use no xylose for 
induction, traces of YFP-MreB fluorescence can still be visualized (Figure 26 C) 
because the xylose promoter is a leaky promoter.  
The image of B. subtilis YFP-MreB epifluorescence microscopy showed that MreB 
localizes as extended but discontinuous filaments along the lateral membrane and 
MreB also has a patchy and short filamentous structure. Most of the filaments extend 
about the entire cell width (around 1.1 µm), some filaments even expand more than 
half of the cell circumference. Furthermore, a minor fraction of MreB formed short 
filaments [172]. From the microscopy image we concluded that the orientation of 
MreB filaments was extremely variable, and the distribution of MreB filaments was 
irregular, as was shown in previous studies [172]. TIRF microscopy could detect 
fluorescence within a focal plane of about 100 nm in depth, while the minimal radius 
for the rod shaped B. subtilis is 500 nm. So the TIRF microscopy could not be the best 
to visualize the MreB fluorescence structures that extend over the entire width of 
membrane. This could be also the reason why MreB has different localization types 
with different microscopy technology. In Gram-negative bacteria E. coli, MreB 
localized the same as in B. subtilis (Figure 26 A and D). 
The proteins of MreC and MreD are colocalized with MreB. MreC and MreD were 
first tagged with GFP or YFP, then integrated into the amy locus of B. subtilis 
chromosome. The localization of GFP-MreC (Figure 26 E) and GFP-MreD (Figure 26 
F) showed the same pattern of a membrane staining (Figure 25 F), which indicates 
that MreC and MreD might membrane proteins. In the constructs of YFP-MreC and 
YFP-MreD, they not only have a same localization as membrane staining, but also 
form some patchy spots within the cell (Figure 26 G and H).  
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Figure 26. Localization study of MreB, MreC and MreD. (A) TIRF image of YFP-MreB::amy 
with full xylose (0.5%) induction. (B) TIRF image of YFP-MreB::amy with medium xylose 
(0.1%) induction. (C) TIRF image of YFP-MreB::amy without xylose induction. (D) TIRF 
image of GFP-MreB with IPTG full induction in E. coli. (E) TIRF image of GFP-MreC::amy 
with full xylose (0.5%) induction. (F) TIRF image of GFP-MreD::amy with full xylose 
induction. (G) TIRF image of GFP-MreC::amy with full xylose induction. (H) TIRF image of 
GFP-MreD::amy with full xylose induction. All the localization experiments were done in 
exponential growing B. subtilis (grow as chains) or E. coli, the experiment of image D was 
performed in E. coli, the rest were performed in B. subtilis. White bar 2 µm.  
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3.4.2 Localization studies of PDH complex in B. subtilis 
The pyruvate dehydrogenase (PDH) complex consists of four subunits: E1 (PdhA and 
PdhB), E2 (PdhC) and E3 (PdhD). Each genes (pdhA, pdhB, pdhC, pdhD) of PDH 
complex was fused with fluorescence protein gene yfp into pSG1164-NLMV vector 
by the C-terminal. These genes were integrated into the chromosome of B. subtilis 
with a single cross-over, so these genes are under the control of original pdhABCD 
promoter.  
PdhA showed polar localization in exponential growth phase B. subtilis, and localized 
as foci at the cell pole with different intensity (Figure 27). The cells with bright foci, 
faint foci and no foci account for around one third of the total population for each 
type of localization. PdhB distributed uniformly under the lateral membrane and 
within the cytoplasm of the cell (Figure 27 B). PdhC also showed a uniform and 
diffuse pattern of localization, which is the same as PdhB (Figure 27 C). We detected 
two types of localization pattern for PdhD. One pattern showed PdhD might have a 
strong DNA affinity, because the illumination of PdhD is overlapped with DNA 
staining (Figure 27 D). The other pattern is the same as PdhB and PdhC, which 
uniformly distributed in the cytoplasm (Figure 27 D). 
 
Figure 27. The localization study of PDH complex subunits was performed in chains of 
exponential growing B. subtilis cells. A, B, C and D represent the localizaiton study of PdhA, 
PdhB, PdhC and PdhD, respectively. Red: membrane staining. Yellow: YFP signal. Green: 
DAPI staining. White bar 2 µm. 
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3.4.3 Localization study of RodZ, PfkA, Pbp1A, RecX and YfhH in B. subtilis 
RodZ (or YmfM) is responsible for the cell shape determination and maintenance in B. 
subtilis, which is also a membrane protein and colocalizes with MreB [82]. The rodZ 
gene was fused with yfp into pSG1729 vector by its N-terminal or fused into 
pSG1164-NLMV vector by its C-terminal. The performed TIRF microscopy of YFP-
RodZ in the exponential B. subtilis showed that it is localized as the membrane 
staining, the illumination density of YFP-RodZ is uniformly distributed on the 
membrane (Figure 28 A). RodZ-YFP in B. subtilis also localized on the membrane and 
uniformly distributed (Figure 28 B), which is the same as YFP-RodZ. These results 
indicate that RodZ is a membrane protein.  
The localization of YFP-Pbp1A in B. subtilis has a same pattern as the membrane 
staining, which indicate Pbp1A is also a membrane protein (Figure 28 D). The 
fluorescence density of YFP-Pbp1A is lower if compared with the density of YFP-
RodZ or RodZ-YFP, which indicate the copy number of Pbp1A is lower than RodZ in 
the exponential growth of B. subtilis.  
The pfkA and recX gene was also fused with yfp by its C-terminal into pSG1164-
NLMV vector. The experiment of PfkA-YFP epifluorescence microscopy in 
exponential growing B. subtilis showed that it is uniformly distributed in the 
cytoplasm of cell (Figure 28 C). This means that PfkA is probably a cytoplasmic 
protein.  
RecX-YFP protein is mainly localized at the cell poles (Figure 28 E). yfhH, which was 
amplified with primers yfhHSalIF1/yfhHEcoRIR1-198, was fused with yfp by its N-
terminal into pHJDS vector. The signal of YFP-YfhH is uniformly distributed within 
the cell (Figure 28 F), which is same as PfkA-YFP. Therefore, YfhH is probably also a 
cytoplasmic protein. 
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Figure 28. Localization study of RodZ, PfkA, Pbp1A, RecX and YfhH in the exponential 
growth B. subtilis (grow as chains). A, B, C, D, E and F represent the localization study of 
YFP-RodZ, RodZ-YFP, PfkA-YFP, YFP-PbP1A, RecX-YFP and YFP-YfhH, respectively. 
The red color is the signal of membrane staining, the yellow color is the signal of RecX-YFP. 
White bar 2 µm. 
3.5 Single molecule microscopy 
To gain further insights into the dynamics and movement of the single particles of 
MreB and other proteins, single molecule microscopy was performed. This technique 
uses fluorescent protein tags, a focused laser beam exictes and bleaches the 
fluorescent protein fusions, and images are acquired in stream acquisition. High 
aperture objective and sensitive cameras make the stream acquisition of single GFP or 
YFP molecules in real-time available. All fused proteins except PfkA that used for 
single molecule experiments are expressed under the xylose promoter by genomic 
recombination with chromosome DNA at the amy site, all the proteins were fused to 
one of the GFP variants YFP. Because the single molecule microscopy is usually 
limited with low copy proteins, the expression level of high copy proteins needs to be 
repressed. We put the genes under xylose promoter without any xylose induction 
since pxyl is a leaky promoter so the single molecule level can be reached. Single 
molecule microscopy was performed to determine the dynamic behavior of proteins in 
vivo. The images were acquired with 10 ms exposure time and 10 ms time interval, 
the frames of each movie was adjusted accordingly, and the intensity of laser beamer 
was used at 10 mW. The parameters (frame number, acquisition interval, voxel depth 
and pixel size) of each imaged movies were first calibrated by program 'Fiji ImageJ' 
and the brightness and contrast were adjusted properly. Then the movement of each 
single molecules was tracked by u-track with the program MATLAB, the data from 
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processed movies was analyzed by msd-analyzer and MicrobeTacker with MATLAB. 
The data I obtained was further analyzed by Dr. Thomas Rösch (University of 
Marburg). 
3.5.1 Single molecule detection and identification 
In the first frame of the time lapse, fluorescence of all YFP fused proteins was 
detectable. YFPs bleach randomly in the following frames and in later frames there 
will be a few molecules left and they switch from the fluorescent state ('blink') to the 
state in which they lose the fluorescence [173]. Therefore, the single molecules can be 
detected and the intensities of the YFPs can be measured. Single molecules tracking 
were performed by using u-track of Matlab plugin, trajectories shorter than 5 frames 
were discarded. And most of the proteins that we analyzed contained two kinds of 
behavior, one kind is highly static and the other one is mobile. 
The images below (Figure 29) showed the fluorescence of single molecules over time 
(each frame is 10 ms). The single molecule can be clearly visualized in frames, the 
ones that blinked can be recognized as one single molecule. The numbers 1, 2, 3, 4 in 
A and B stand for tracks, number 2 (yellow) track in image A is quite dynamic while 
the number 1 (red) and 3 (green) tracks in image A are quite static. The red circle in 
image C is a static single molecule. There are also some molecules that blink in one 
frame and disappear in the next frame and therefore cannot be tracked so they must be 
freely diffusing within the cell and out of the focus layer very fast. The PfkA-YFP 
fusion molecules were very difficult to track, because PfkA is under the original 
promoter and PfkA is over expressed. So it is very hard to distinguish the single 
molecules. Tracking of YFP-MreB molecules indicated that there are two fractions: 
one is immobile and the other one is mobile. Figure 29 gives examples of mobile 
spots that moved for a few frames and then photobleached, it also gives examples of 
static spots that are immobile for a few frames and then photobleached. 
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Figure 29. Single molecule detection and tracking in exponential growth B. subtilis cells. 
From left to right, they are YFP-MreB, YFP-MreC and YFP-MreD fusions, respectively. (A) 
Example tracks of YFP-MreB spots that are mobile and static before photobleaching. Number 
1 (in red color) and 3 (in green color) are the dynamic spots and number 2 (in yellow color) is 
the static spot. (B) Mobile and static spots example of YFP-MreC. (C) Example of single 
molecule detection, the one in red circle is recognized as one molecule. Single molecule 
acquisition with time interval of 10 ms, each frame has an exposure time of 10 ms. There is 
more than one single molecule in one plane but some are photobleached and some others 
appear over time. The full set of pictures contain from 1000 to 5000 frames. Scale bars 2 µm.  
3.5.2 Tracking analysis of YFP-MreB and PfkA-YFP single molecules 
B. subtilis with YFP-MreB or PfkA-YFP fusions were grown in S750 minimal 
medium without xylose induction. Because pfkA is driven by the original promoter, 
mreB is under the control of leaky xylose promoter, and the leaky level of expression 
is enough for us to visualize the single molecules. The dynamics of YFP-MreB and 
PfkA-YFP was investigated by stream acquisition of single molecule microscopy. To 
determine the movement speed of single mobile molecules, the diffusion coefficients 
were determined using msd-analyzer plugin together with MATLAB program. From 
the tracks that were analyzed by the U-track plugin of MATLAB, the mean square 
displacement (MSD) of each trajectory were calculated and the first 25% of a MSD 
versus time curve were fitted linearly. The diffusion coefficients were calculated from 
the slope of these fits. Actin accounts approximately 10-15% of total cell protein in 
the average eukaryotic cells. Actin can be divided into two categories: one is a free 
monomer called G-actin (globular), the other one is a linear polymer microfilament 
called F-actin (filamentous) [174]. Prokaryotes also contain proteins that are highly 
similar to actin monomers and polymers. The bacterial protein MreB polymerizes into 
filaments similar to F-actin [175, 176]. The crystalline structure of MreB is very 
similar to that of G-actin (three-dimensional conformation) [114]. In B. subtilis, there 
are approximately 8000 MreB molecules, which were calculated by using quantitative 
western-blot [174]. In some eukaryotic cells (e.g. Swiss 3T3 cells, Asterias or Thyone 
sperm), approximately 80% of actin is in the monomeric state (G-actin) [177-179]. 
A former study of our laboratary has shown that MreB filaments consist of two 
different populations, an exchangeable and a non-(or very slowly) exchangeable 
fraction. More than 50% of MreB molecules are associated with the polymerized 
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fraction. Thus, at least half of the MreB molecules are within filamentous structures 
and are not available for exchange [95]. Our results of single molecule tracking also 
showed that MreB molecules are composed of two populations. One is immobile 
which has a diffusion coefficient (D, µm2/s) of 0.060 and account for 53.1% of the 
total population. Another one is the mobile population with a diffusion coefficient of 
0.463 and account for 46.9% of the total population (Figure 30). Immobile (or static) 
MreB molecules (more than half of the total population) are within MreB filamentous 
structures, the remainder of MreB molecules (less than half of the total population) 
are mobile and freely diffusing within the cytoplasm. These results are in accordance 
with the former studies of our laboratary [95].  
Single molecule tracking analysis of PfkA-YFP revealed that there are two 
populations (we can also see it as one moving population since one plot curve of 
Gaussian fit can also explain the movement well, Appendix Figure 36 D2) of moving 
fraction and no static molecules could be detected. One population is highly dynamic, 
which has a diffusion coefficient of 0.755 and accounts for 49.3% of total molecules. 
Another population is composed of slow moving molecules, which has a diffusion 
coefficient of 0.232 and accounts for 50.7% of total population (Figure 30). However, 
because a diffusion coefficient of 0.2 is still much higher than that of a static MreB 
molecule, there is likely only one dynamic PfkA population with a wide range of 
diffusion rates. Both the diffusion coefficient and proportion of highly dynamic YFP-
MreB molecules are lower than those of PfkA-YFP. 
 
Figure 30. Diffusion coefficients. The mean diffusion coefficient of mobile and static YFP-
MreB were 0.463 (with a fraction of 46.9%) and 0.060 (53.1%) µm2/s, respectively. The 
mean diffusion coefficient of two PfkA-YFP mobile populations were 0.232 (50.7%) and 
0.755 (49.3%) µm2/s. The round circles represent the movement behavior of YFP-MreB. The 
triangles represent the movement behavior of PfkA-YFP. The X axis shows the diffusion 
coefficient of each population, the Y axis shows the fraction of each diffusion coefficient. 
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MreB has high membrane affinity, and localized underneath the lateral membrane. 
The focus plane was at the bottom of the cell during the slim-field movie capture. The 
localization of single molecule spots is denser in the middle of the cell than at the 
edge of cell from the horizontal direction (Figure 31 B1 and D1). This result is in 
accordance with our knowledge of MreB localization because MreB is a membrane 
protein so we lose the focus at the cell edges when we focus at the bottom of the cell. 
From the vertical direction, we observed the density of MreB spots is higher at some 
position than others, which indicates that MreB has some preferable localization place 
and formed the filaments structure, and the spots density at the cell poles is much 
lower than in the cell center (Figure 31 B1 and C1). These results are in accordance 
with the result that MreB forms filaments underneath the cell membrane (Figure 26 
A). The cumulative density function (CDF) fitting of single molecule step size 
distribution was also used to determine the moving behavior of tracks. For YFP-MreB, 
the fitting curve with one mobile and one immobile population fitted very well with 
the experimental data (Appendix Figure 36 F1). For PfkA-YFP, the fit with two 
mobile populations explains very well of the experimental data (Appendix Figure 36 
F2).  
The bottom of the cells were focused when the single molecule microscopy was 
performed. The movement overlay and the spots density of YFP-MreB showed a 
pattern that similar to membrane staining (Figure 31 A1 and B1). This indicates that 
MreB is a membrane-associated protein. The movement of YFP-MreB and the 
density of spots were not or (at least) less observed along the cell edges and the cell 
poles, which further proved that MreB is a membrane associated protein. The 
localization of PfkA-YFP is more uniformly distributed within the cytoplasm of cell.  
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Figure 31. Single molecule tracking and spots localization study. (A) Overlay of single 
molecule tracking. A1 and A2 are overlays of single molecule trajectories of YFP-MreB and 
PfkA-YFP that obtained in exponentially growing B. subtilis cells. Trajectories longer than 5 
frames were analyzed. In both A and B images, the X axis represents the cell length, the Y 
axis represents the cell width. (B) Heatmap of spots localization, which represents the density 
of single molecule spots. The gradient bar on the right side of each heatmap stands for the 
density of each color, from above (yellow) to bottom are gradient densities from 100% to 
10%. (C) Normalized X-localization. The X axis represents the cell length; the Y axis 
represents the density of spots along the cell length. (D) Normalized Y-localization. The Y 
axis represents the cell width; the X axis represents the probability density of spots along the 
cell width. Images were created by Dr. Thomas Rösch. 
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3.5.3 Single molecule analysis of MreC, MreD, RodZ and Pbp1A 
The data analysis from u-track and msd-analyzer of YFP-MreC, YFP-MreD, YFP-
RodZ and YFP-Pbp1A showed that the movements of their single molecules consist 
of two populations. One is the static population, another one is the highly dynamic 
population. YFP-MreC and YFP-MreD (Figure 32) have the similar moving behavior 
as the YFP-MreB (Figure 30). The reason is that MreC and MreD are colocalize with 
MreB. YFP-RodZ, which is also an MreB-associated protein, has a similar moving 
behavior as the YFP-MreB. Pbp1A, which is a key enzyme of the cell wall 
biosynthesis machinesry and belong to the PBPs, has a mobile fraction with the 
highest diffusion coefficient (0.812 µm2/s). More than half of the total population of 
YFP-MreC, YFP-MreD and YFP-Pbp1A single molecules belong to the immobile 
fraction, while 42.1% of YFP-RodZ single molecules are static. The localization of 
MreC (Figure 26 E and G), MreD (Figure 26 F and H), RodZ (Figure 28 A and B), 
Pbp1A (Figure 28 D) shows they are membrane proteins as MreB. 
 
Figure 32. Diffusion coefficients. The mean diffusion coefficients of mobile and static YFP-
MreC were 0.548 (32.3%) and 0.060 (67.7%) µm2/s, respectively. The mean diffusion 
coefficients of mobile and static YFP-MreD were 0.481 (39.7%) and 0.056 (60.3%) µm2/s. 
The mean diffusion coefficients of mobile and static YFP-RodZ were 0.483 (57.9%) and 
0.076 (42.1%) µm2/s. The mean diffusion coefficients of mobile and static YFP-Pbp1A were 
0.812 (48.3%) and 0.093 (51.7%) µm2/s. The round circles represent the movement behavior 
of YFP-MreC. The triangles represent the movement behavior of YFP-MreD. The squares 
represent the movement behavior of YFP-RodZ. The diamonds represent the movement 
behavior of YFP-Pbp1A. The X axis shows the diffusion coefficient of each population, the Y 
axis shows the fraction of each population. 
The fit plot of Gaussian distribution (Figure 33 A) and CPD (cumulative probability 
density function, data not shown) of YFP-MreC, YFP-MreD, YFP-RodZ and YFP-
 71 
Pbp1A showed that the single molecules consist of two populations. One is the 
immobile population, the other one is the mobile population. The superposition plot 
curve of two populations fitted very well with the Gaussian distribution of our 
experimental data (Figure 33 B). The heatmap of spots localization of YFP-MreC and 
YFP-MreD showed that MreC and MreD are widely distributed within the cell, and 
they have some preferable localization place in the cytoplasm of cell (Figure 33 C1 
and C2). The density of YFP-MreC and YFP-MreD single molecules is higher at 
some places, this result is in accordance with the localization study of YFP-MreC and 
YFP-MreD by using epifluorescence microscopy (Figure 26 G and H). YFP-RodZ 
and YFP-Pbp1A are widely distributed inside the cytoplasm (Figure 33 C3 and C4), 
RodZ and Pbp1A are membrane proteins (Figure 28 A and D). Since MreC, MreD, 
RodZ and Pbp1A are membrane proteins, their single molecule spots have similar 
localization patterns (Figure 33), but the movement speed of mobile Pbp1A single 
molecules is the highest among all of these membrane proteins. 
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Figure 33. Single molecule tracking analysis and the study of spots localization. (A) Track 
lengths in frames. The X axis stands for the frame interval of each spot, the Y axis stands for 
the number of frame interval. (B) Two populations fit of Gaussian distribution. The X axis 
represents each moving behavior. The Y axis represents the density of each moving behavior. 
The green curve represents the superposition plot of two populations fit. The dotted red curve 
represents the Gaussian fit of the immobile population, the dashed red curve represents the 
Gaussian fit of mobile population. (C) Heatmap of single molecule spots localization. The X 
axis represents the cell length, the Y axis represents the cell width. The gradient bar on the 
right side of each heatmap stands for the density of each color, from above (yellow) to bottom 
there is a gradient density from 100% to 10%. Images were created by Dr. Thomas Rösch. 
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3.5.4 Single molecule analysis of pyruvate dehydrogenase (PDH) complex 
The pyruvate dehydrogenase (PDH) complex catalyzes the conversion of pyruvate to 
acetyl-CoA and CO2 [180]. PDH is a large complex, which contains multiple copies 
of three enzymatic components: pyruvate dehydrogenase (E1, α and β subunits are 
PdhA and PdhB), dihydrolipoamide acetyltransferase (E2, PdhC) and lipoamide 
dehydrogenase (E3, PdhD). In Gram-negative bacteria, the central core of PDH 
complex contains 24 molecules of E2 (PdhC) [143]. Up to 24 copies of E1 (PdhA and 
PdhB) and 12 copies of E3 (PdhD) bind to the E2 core [181]. In Gram-positive 
bacteria and eukaryotes, the PDH complex consists of a central icosahedron core that 
is made up of 60 E2 (PdhC) molecules, and 30 E1 (PdhA and PdhB) and 6 E3 (PdhD) 
subunits bind to this core [142]. Eukaryotes contain 12 copies of an additional core 
protein, E3 binding protein (E3BP). In yeast, E3BP binds to each of the icosahedral 
faces [182].  
The data analysis of PDH complex single molecule tracking showed that each subunit 
of PDH is composed of two populations. One is the mobile population, which is 
highly diffusing within the cell. The other one is the immobile population, which 
forms the PDH complex. We can distinguish which subunit of PDH is the core of the 
complex by analyzing the fraction and the diffusion coefficient of each population. 
From four PDH subunits, the E2 (PdhC) core has both the lowest fraction (27.0%) 
and the lowest diffusion coefficient (0.357 µm2/s) of the mobile population in 
comparison with the other 3 subunits (Figure 34). These results further prove that E2 
is the core of PDH complex, because the other subunits need to bind to this core, 
which makes them more dynamic. Therefore, the core of the complex must be more 
static and the fraction (73.0%) of static molecules must be higher than in the other 
subunits of PDH. The E2 subunit is needed in bigger amounts than the E1 (PdhA and 
PdhB) and E3 (PdhD) subunits, therefore, the fraction of static E2 single molecules is 
higher than that of E1 and E3 subunits. 
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Figure 34. Diffusion coefficients. The mean diffusion coefficients of mobile and static YFP-
PdhA were 0.642 (with a fraction of 35.6%) and 0.103 (with a fraction of 64.4%) µm2/s. The 
mean diffusion coefficients of mobile and static YFP-PdhB were 0.825 (58.4%) and 0.084 
(41.6%) µm2/s. The mean diffusion coefficients of mobile and static YFP-PdhC were 0.357 
(27.0%) and 0.068 (73.0%) µm2/s. The mean diffusion coefficients of mobile and static YFP-
PdhD were 0.675 (47.3%) and 0.079 (52.7%) µm2/s. The round circle represents the 
movement behavior of YFP-PdhC. The triangle represents the movement behavior of YFP-
PdhA. The square represents the movement behavior of YFP-PdhB. The diamond represents 
the movement behavior of YFP-PdhD. The X axis shows the diffusion coefficient of each 
population, the Y axis shows the fraction of each population. 
The fit plot of Gaussian distribution (Figure 35 A) and CPD (cumulative probability 
density function, data not shown) of YFP-PdhABCD (each subunits of PDH) showed 
that their single molecules are make up of two populations. One is the immobile 
population, the other one is the mobile population. The superposition plot curve of 
two populations fitted very well with the Gaussian distribution of our experimental 
data (Figure 35 A). The heatmap of spots localization of YFP-PdhB, YFP-PdhC and 
YFP-PdhD showed that PdhB, PdhC and PdhD are widely and uniformly distributed 
within the cytoplasm of cell (Figure 35 B2 and B3). This result is in accordance with 
the localization study of PdhB and PdhC by using epifluorescence microscopy (Figure 
27 B and C). The heatmap of YFP-PdhA single molecule spots localization showed 
that PdhA is localized at one cell pole, this result is also in accordance with our 
localization study of PdhA (Figure 27 A).  
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Figure 35. Single molecule tracking analysis and the spots localization study of PDH complex 
subunits. (A) Two populations fit of Gaussian distribution. The X axis represents each 
moving behavior. The Y axis represents the density of each moving behavior. Two red curves 
represent the plot of two populations. The green curve represents the superposition plot of 
two populations fit. The dotted red curve represents the fit of immobile population; the 
dashed red curve represents the fit of mobile population. (B) Heatmap of single molecule 
spots localization. The X axis represents the cell length, the Y axis represents the cell width. 
The gradient bar on the right side of each heatmap stands for the density of each color, from 
above (yellow) to bottom are gradient density from 100% to 10%. Number 1-4 represents the 
analysis of YFP-PdhA, YFP-PdhB, YFP-PdhC and YFP-PdhD, respectively. Images were 
created by Dr. Thomas Rösch. 
3.6 Conclusion 
Our results showed that the purified lytic enzyme LytC could inhibit the growth of 
Gram-negative E. coli and Gram-positive B. subtilis. LytC is moderately stable and 
not a monomeric protein. The use of BSA as control shows that the inhibition is 
caused by the LytC enzyme rather than any ordinary protein. The deletions of the 
trans-membrane domain, the CWB domain and the LCR domain do not affect the 
activity of LytC. The C-terminal construct of LytC with a strep-tag worked while the 
N-terminal fusion of GST-His tag to LytC failed. Site directed mutagenesis (a.a. 342 
and 461) in functional region did not cause activity loss of LytC. The activity 
comparison between LytCF2 and LytCF2R2 (functional region partially deleted) 
shows that it is the functional region that determines the catalytic ability. The deletion 
of functional region could cause the loss of activity. We microscoped the cells that 
were treated with LytC to see the phenotype after cell growth inhibition. We observed 
that in the cells that were treated with LytC, some cells were dead because of the cell 
wall break down. In survived cells, the spherical or elliptical cell-shapes instead of the 
original rod-cell shape were observed. 
We used PfkA-YFP as a control to compare the moving behavior of its single 
molecules with YFP-MreB. Diffusion coefficient and single molecule analysis of 
YFP-MreB showed that more than half of MreB molecules are static (Figure 30, 
Appendix Figure 36 E1 and F1). Less than half of rapid moving YFP-MreB 
molecules were also observed, these molecules are the ones that freely diffuse within 
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the cell. According to the Gaussian and CDF fit, YFP-MreB has a fraction of 53.1% 
of immobile molecules and 46.9% of mobile molecules. PfkA-YFP does not have 
static molecules, the highly dynamic population accounts for 49.3% with a diffusion 
coefficient of 0.755 µm2/s, the relatively slower dynamic population accounts for 53.1% 
with a diffusion coefficient of 0.232 µm2/s. We concluded that MreB is much more 
static and has more static fraction molecules than PfkA. The heatmap of MreB single 
molecule localization further proved that MreB is a membrane protein. The fraction 
and the movement speed of mobile MreC, MreD, Pbp1A and RodZ are in a similar 
pattern with the movement of MreB, because those proteins are membrane-associated 
proteins. The single molecule data analysis of PDH subunits showed that E2 (PdhC) 
has both the lowest fraction (27.0%) of mobile population and movement speed 
(0.357 µm2/s) of all four subunits. Thus, PdhC is the most static subunit of all four 
PDH subunits. These results suggest that E2 is the core of PDH in vivo.  
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4 Discussion 
For many years people tried to explore the next generation of wide range antibiotics 
since ampicillin was first discovered, and a lot of effort was focused on discovering 
the ones that bind to cell wall biosynthesis machinery enzymes such as the PG 
biosynthesis machinery and PBPs. We provide a new idea to find the next generation 
antibiotics, we mainly focus on the cell wall degradation enzymes which can cause 
the break down of cell wall, furthermore, cell membrane breaks. And one advantage 
of these enzymes is they work on all the bacteria that have the cell wall, and they 
function in the periplasm and will not easily induce the antibiotic resistance. Our 
results showed the potential of a cell wall breakdown enzyme can be applied for 
industrial usage. 
LytC kills host during incubation 
We already overexpressed several constructs successfully. E. coli BL21 (DE3) was 
used for protein overexpression. After induced by IPTG, cells started to lyse after 1 
hour of incubation, so it is hard to harvest enough amount of pellets to continue the 
research. After we managed to obtain enough proteins, we wanted to know if those 
constructs can lyse cells (we used living organisms E. coli and B. subtils as objects), 
we added purified protein into cell culture (strep elution buffer used as control) and 
discovered that purified LytC protein can greatly inhibit the growth of bacteria. With 
the aid of microscopy, we confirmed that the cell wall of E. coli and B. subtilis is 
indeed lysed after cells were treated with LytC. We used BSA as control to make sure 
that it is not just any ordinary protein that can lyse cell wall but the cell wall lyse 
protein LytC. Finally we found out that cells with BSA grow slightly better than the 
ones without BSA (we suppose that cells can use protein as one nutrition source). 
LytC is not a monomer and is moderately stable 
Our proteins can keep activity over one week at 4°C or over 24 hours at room 
temperature, and can be stored at -20°C or -80°C and keep most activity after once 
frozen. However, two main problems exist. One is that during the overexpression step 
LytC kills the host cells so the production of LytC is not very high. The other one is 
chaperones were produced for some of our constructs (LytCF2, LytCF3 and LytCF4) 
probably because the protein was not correctly folded which causes the impurity of 
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the protein. When we concentrated the LytC proteins by ultrafiltration, we used 
columns that have much bigger molecular weight membrane (only the proteins have 
bigger MW can be concentrated, the rest small proteins will pass through the 
membrane). Yet the LytC proteins still blocked by the membrane (confirmed by 
western-blot of the pass through and membrane blocked parts). This indicates the 
LytC proteins are not monomer. Since the purified LytC was not monomer, it is not 
easy to separate the chaperones from the desired protein by gel filtration. 
LytC keeps its function only by C-terminal fusion and kills bacteria during 
exponential growth  
We wanted to enhance protein production by fusing our constructs with GST-His tag 
since it is a widely used tag for protein overexpression. Unfortunately, some 
constructs did not work in the test expression step and some did not work in the 
purification step and some do not have the inhibition effect on bacterial growth. The 
only successful purified construct is GSH-His-LytCF6, but the results of this 
construct did not fulfill our expectations since it had a slight inhibition on the growth 
of E. coli (Figure 16 C), because the inhibition effect of this construct did not have any 
advantage in comparison with other C-terminal strep-tagged LytC constructs (e.g. 
LytCF6). The N-terminal fusion might caused the mis-folding of LytC.  
Pneumococcal LytC can kill cells that are in early exponential phase maybe because 
the LytC from pneumococcus is only able to hydrolyze non-cross-linked PG chains so 
probably the same applied to the LytC of B. subtilis [63]. The attempt to track the 
process of bacterial cell wall breakdown and cell death under high resolution 
microscopy was not successful and the test digest of cells from plates did not work as 
we expected. We assume the reason should be that LytC only works for bacteria that 
are in exponential phase, or in other words that LytC can only inhibit cell growth but 
can not hydrolyze the cell wall that in stationary phase. Another reason is that bacteria 
need longer time for growing on plate than in liquid medium so that the LytC was 
probably already degraded by the proteases that secreted by the cells. The reason for 
the failure of live cell lysing visualization could be that when cells are attached with 
S750 agar, the cells start to absorb nutrition from S750 solid medium instead of liquid 
medium and the effective concentration of LytC decreased in comparison with in 
liquid culture. 
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Functional region rather other domains work as bacteria inhibitor 
We made 6 constructs of LytC (from LytCF1 to LytCF6) that fused with strep-tag at 
the C-terminal. Purification of LytCF1 failed (Figure 11 D). LytCF3 was not very 
pure after the strep-tag column purification and even after gel filtration, there is 
always a un-wanted band (Figure 11 A and C). The reason could be that the impurity 
chaperones have similar molecular weight as non-monomeric state LytCF3. The 
situation for LytCF4 was similar to LytCF3, the purity of LytCF4 is not high enough 
for precise analysis (Figure 12 A and B). The production of LytCF6 (Figure 12 C and 
D) is too low in comparison with LytCF2 and LytCF5, so the further usage of LytCF6 
had to be limited. We mainly used the constructs of LytCF2 and LytCF5 for the study. 
Bacteria E. coli and B. subtilis were used for the inhibition test: the purified LytCF1 
was not obtained so that the inhibition test was not performed; LytCF2 can greatly 
inhibit the growth of E. coli (Figure 15 A and B) and B. subtilis (Figure 15 C) with a 
final concentration of 7.6 mM and 17 mM, respectively. LytCF3 can inhibit the 
growth of E. coli with a final concentration of 3.1 mM (Figure 15 D). LytCF4 can 
inhibit the growth of E. coli BL21 with a final concentration of 10.2 mM (Figure 16 A). 
The purified LytCF5 protein can greatly inhibit the growth of E. coli and B. subtilis 
with a final concentration of 1.8 mM and 8.3 mM, respectively, and this have been 
proved by several repeats (Figure 17 and Figure 18). The purified LytCF6 protein 
proved again that LytC can inhibit the growth of E. coli with a final concentration of 
1.3 mM. We proved that LytC can function without the trans-membrane region. LytC 
can function when „low complexity region“ (LCR) is partially deleted (LytCF3) or 
totally removed (LytCF2, LytCF5 and LytCF6). LytC can function when two cell 
wall binding (CWB) regions were removed (LytCF3 and LytCF2) and even all three 
CWB regions were removed (LytCF5 and LytCF6). LytC can function as long as the 
functional region is kept, LytC kept the lytic activity when only the functional region 
was kept (LytCF6). We conclude that the trans-membrane region, CWB regions and 
LCR are not necessary for the activity of LytC. Chaperones were formed in the 
constructs of LytCF2, LytCF3 and LytCF4. Therefore, in these constructs the LytC 
proteins could not be folded properly and this affected the purity and activity of LytC, 
which caused an imprecise calculation of LytC concentration.  
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Defect of LytC functional region causes activity loss 
To further prove it is the function region of LytC inhibit the growth of bacteria and 
degrad the cell wall, the site-directed mutagenesis and functional region partially 
deletion were performed. In the LytC mutation experiments, we chose the LytCF5 
construct for producing site-directed mutants. The single site-directed mutation and 
double sites mutation results showed that the sites we mutated are not the key amino 
acid points for the function of LytCF5 (Figure 22 and Figure 23). LytCF2 construct 
was chosen for the partial deletion experiment, the activity of LytCF2R2 (partial 
deletion construct) was lost in almost half if compared to that of LytCF2 for E. coli 
(Figure 24 A and B), the activity of LytCF2R2 was also partially lost for B. subtilis 
(Figure 24 C). Therefore we proved it is the functional region of LytC protein that 
inhibits cell growth. Yet the evidence was not enough for us to conclude that LytC 
can break down the cell wall, we needed visual proof to see what happened to the 
cells after treated with LytC and what kind of damage LytC could cause. E. coli of 
XL1 and BL21 and B. subtilis PY79 that treated by LytCF5 and LytCF6 samples were 
used for microscopy. In the treated E. coli samples, we captured images of cells that 
were dead probably because of the degradation of cell wall (Figure 25). There were 
also some cells that still survived even after they lost the cell wall but those cells had 
a new spherical cell-shape instead of the normal rod-cell shape (Figure 25). In the 
treated B. subtilis samples, the dead cell images were not so widely captured as E. coli 
because the gram-positive bacteria B. subtilis have thicker cell wall than the gram-
negative E. coli. Dead B. subtilis cells that loss their cell wall were also visualized 
(Figure 25). Even though most B. subtilis cells survived, the survived ones partly lost 
their cell wall and could not maintain the rod-cell shape. The new cell shape is neither 
like rod shape nor like spherical shape since part of the cell wall was still left 
surrounding the cell membrane (Figure 25). 
Localization study of proteins in vivo 
The localization study of YFP-MreB in exponential growth B. subtilis showed that 
MreB localized underneath the lateral membrane as a discontinuous filament structure. 
Some MreB filaments are long and can extend over the entire cell width and even 
more than half of the cell circumference, while some filaments are rather short. 
Patchy spots of MreB localization pattern were also observed (Figure 26 A). When 
the expression level of MreB was decreased, most of the long filament structure was 
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lost and the short filaments or spots localization started to appear (Figure 26 B). If we 
totally cut off the expression of YFP-MreB by removing xylose induction, very weak 
of MreB illumination signal was still recorded because of the leaky xylose promoter. 
We expressed the GFP-MreB in two E. coli strains, the gfp-mreB was integrated into 
the chromosome in one strain and gfp-mreB was cloned into a vector in other strain. 
The expression of GFP-MreB showed that MreB has the same localization pattern in 
Gram-negative bacteria E. coli as in Gram-positive bacteria B. subtilis (Figure 26 D, 
the localization of GFP-MreB in the vector-transformed strain was not shown since it 
is the same as in the case of chromosome recombination). GFP-MreC and GFP-MreD 
in exponential B. subtilis localized on the membrane, with the same localization 
pattern as membrane staining (Figure 26 E and F). YFP-MreC and YFP-MreD 
proteins showed a more defined localization pattern than the GFP-tagged ones, they 
also have patchy spots localization within the cell besides the localization pattern of 
membrane staining. These results showed that MreB, MreC and MreD are membrane 
proteins and they colocalized.  
RodZ and Pbp1A also play a key role in the cell shape determination and maintenance, 
and RodZ also colocalized with MreB. YFP-RodZ and YFP-Pbp1A have the same 
localization pattern as membrane staining which is also similar to MreB, MreC and 
MreD localization. The illumination signal of MreC and Pbp1A is lower than that of 
MreB and RodZ, while the signal of MreD is the most moderate among those five 
proteins (Figure 28 A, B and D). These results indicate that the copy number of MreC 
and Pbp1A is lower than that of MreB and RodZ and the copy number of MreD is 
moderate. And the results also proved that those five proteins are membrane proteins. 
The epifluorescence signals of PfkA-YFP and YfhH-YFP are widely and uniformly 
distributed inside the cell cytoplasm (Figure 28 C and F), this demonstrates that PfkA 
and YfhH are cytoplasmic proteins. In the RecX-YFP constructed strain, we observed 
elongated cells and RecX is prone to localized at one cell pole in exponentially grown 
B. subtilis (Figure 28 E). 
Two subunits of PDH complex, PdhB (E1 β) and PdhC (E2) have the same 
localization pattern, they are uniformly distributed under the lateral membrane and 
within the cytoplasm of the cell (Figure 27 B and C). PdhA (E1 α) localized as foci at 
the cell pole with different fluorescence intensity. From our estimation, one third of 
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the cells have PdhA localized at the cell pole with high intensity, another one third of 
cells have PdhA localized at the cell pole with low intensity, the last one third of cells 
does not contain any PdhA foci. PdhD (E3) has two patterns of localization in B. 
subtilis. In one pattern, the localization of PdhD is overlapped with the illumination of 
DNA staining (Figure 27 D1), which indicates PdhD might have DNA affinity. In 
another pattern, PdhD localized uniformly within the cytoplasm of the cells (Figure 
27 D3), which is the same pattern as PdhB and PdhC. 
Two distinct fractions of YFP-MreB single molecules 
Single molecule microscopy of several proteins was performed in this study. The 
movement of these molecules was tracked both manually and automatically, the 
automatic tracking data were further modified manually and processed. The automatic 
tracking fit our experimental data well most of the time. But some tracks were not 
accurate since the spots disappeared (not only by photobleaching) in some frames 
because some molecules moved out of the focal plane. The single molecules are 
moving in a 3 dimensional space while the single molecules tracking were captured 
by camera in a 2 dimensional plane so there must be some missed tracks or error 
calculation. Another major error source is that the cells we microscoped were alive 
and their positions can be changed casually even the cells were fixed to the agarose. 
Therefore, if a spot moved out of the focus plane or it does not move strictly in the 2 
dimensional plane or the cell changed its position, then the spots cannot be detected 
by the camera or the movement was misrecorded. The new blinked spots were not 
only from the bleached recovery but also from the places that were not in the focal 
plane. Single molecule experiments were performed in real time in living B. subtilis 
cells to investigate the dynamics of MreB. Single molecules of different proteins were 
microscoped in this study. The movement of these molecules was tracked 
automatically, and the automatic tracking followed the spots pretty well. Since the 
cells are alive and can change their position subtly, this will lead to the change of 
focal plane. Some spots could move out of the focal plane, therefore those spots 
cannot be detected or detected with less intensity. This will cause many short tracks 
and further reduce the precision of our data analysis, hence the tracks that were 
shorter than 5 frames were not included. 
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For most of the proteins we tracked, two categories of molecular movements could be 
visualized, a mobile one and a static one. The movement of PfkA-YFP can be divided 
into two mobile categories or one mobile category. The movement speed and fraction 
of each mobile population of proteins were calculated. The single molecules of each 
protein can switch their state between static and dynamic. For example, the freely 
diffusing MreB single molecules can bind to the existing MreB filament structure and 
form the static molecules. The MreB single molecules in filaments can also diffuse 
from the negative end and form the freely diffusing MreB. We used PfkA as the 
control of MreB since PfkA is a fast moving protein. The data analysis of MreB and 
PfkA single molecules showed that MreB is more static while PfkA is freely diffusing 
within the cytoplasm of the cell. Two fractions of YFP-MreB could be distinguished: 
a mobile and a static fraction of molecules. The evaluation revealed that more than 
half MreB molecules are static (53.1% with a D of 0.060 µm2/s) and the rest is highly 
dynamic (46.9% with a D of 0.463 µm2/s). To further elucidate that PfkA-YFP 
consists of two populations of molecules with different mobility, another approach 
based on the fitting of CDF on the distribution of single molecules step sizes was used. 
The fitting with two populations of molecules distribution fitted much better with the 
experimental data than with one mobile population. 
The construct of YFP-MreB we used in this study was at the amy locus of B. subtilis 
and under control of the xylose promoter. MreB can be divided into two categories: 
one category is the native MreB under the original promoter, the other category is the 
constructed YFP-MreB under the xylose promoter. The co-expression of both source 
of proteins will lead to the slightly over expression of MreB proteins. The amount of 
MreB that cell needs to form filaments are static. Therefore, there are more MreB 
molecules in our constructed strain than the wild type B. subtilis. The excessive single 
molecules are freely diffusing within the cell. Those freely diffusing YFP-MreB have 
to compete with native MreB molecules to bind to the MreB filaments, therefore, the 
speed of single molecules movement might also be accelerated. The real diffusion 
coefficient and fraction of mobile MreB single molecules should be lower than our 
data. In reality, MreB single molecules should be more static and the fraction of 
immobile molecules should also be slightly higher than in our data. For the PfkA-YFP 
case, the construct pfkA-yfp replaced the original pfkA gene and was under control of 
its original promoter. Therefore, the single molecule data of PfkA we obtained in this 
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study should be the most accurate one in comparison with other proteins. The effort of 
using E. coli with GFP-MreB construct to perform the single molecule experiment to 
clarify the dynamics of MreB molecules in Gram-negative bacteria failed. It will be a 
good control to compare the MreB moving behavior between Gram-positive and 
Gram-negative bacteria if it succeeded. 
The movement pattern and fraction of MreC, MreD, RodZ and Pbp1A are 
similar to MreB 
The dynamic fraction and movement pattern of MreC, MreD, Pbp1A and RodZ single 
molecules are similar to MreB. These five proteins are all membrane proteins and 
play a critical role in the determination and maintenance of bacterial cell shape. MreC, 
MreD and RodZ colocalize with MreB, RodZ also interacts with other cell shape 
proteins, Pbp1A also plays an important role in cell wall synthesis. All of these 
reasons make MreB, MreC, MreD, RodZ and Pbp1A single molecules have similar 
dynamic movement pattern and fraction. Since YFP-MreC, YFP-MreD, YFP-RodZ 
and YFP-Pbp1A are all at the amy locus and under the drive of xylose promoter. The 
single molecule data we obtained for those proteins are similar to MreB, they are not 
100% precise. In reality, the fraction and the diffusion coefficient of mobile single 
molecules of those proteins should be lower than the data we obtained in this study. 
Single molecule data analysis indicate PdhC is the core of PDH complex 
Single molecule experiments revealed that 73.0% of PdhC are immobile, which is a 
higher percentage than for the other components of PDH (pyruvate dehydrogenase) 
complex. Both the diffusion coefficient (0.357 µm2/s) and fraction (27.0%) of mobile 
PdhC molecules are lower than the rest components of the PDH complex. This further 
demonstrates that PdhC is the core of PDH complex. There is a core (E2) in the 
pyruvate dehydrogenase (PDH) complex, that is why PdhC single molecules are more 
static and move slower than other subunits of PDH complex. The other subunits are 
binding to this core so they need to be more dynamic. The E2 (PdhC) subunit is 
needed more than other subunits in PDH complex, the fraction of immobile PdhC 
single molecules is the highest. This result further proves that the E2 subunit is the 
core of PDH. All four subunits of PDH complex we constructed in this work are at the 
amy locus of B. subtilis, and under the drive of the xylose promoter. Therefore, in B. 
subtilis cells, there are two kinds of proteins for each of our constructs, one kind is the 
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native proteins of PDH complex, the other kind is the constructed YFP-PDH that is at 
the amy locus and under the drive of xylose promoter. The native E1 (PdhA and PdhB) 
and E3 (PdhD) subunits are competing with the constructed E1 and E3 to bind to the 
E2 (PdhC) core of the PDH complex. In some cases, if the the native E1 and E3 single 
molecules are already bound to the E2 cores, the constructed YFP-PdhA, YFP-PdhB 
and YFP-PdhD need to move around to find the unbound cores. Therefore, more 
movement of PDH single molecules were recorded by the microscopy camera, and 
the fraction and the movement speed of mobile single molecules are higher than in 
reality. In the wild type B. subtilis, the native PDH single molecules are more static. 
We need the constructed proteins expressed in single molecule level because too 
much of epifluorescence molecules will interfere with the accuracy of our results, so 
the expression of constructed proteins was strictly controled. Therefore, even though 
our results are not 100% precise to describe the reality, we are trying to get closer to it. 
The same situation applies to the movement of MreB, MreC, MreD, RodZ and Pbp1A.  
We can obtain much information from the single molecule analysis data. For example, 
we can judge if a protein is a membrane protein (MreB) from the heatmap figure of 
single molecule spots localization. We can also tell if a protein is freely diffusing or 
forms filaments or localizes at some positions (e.g. PdhA localizes at cell poles). 
From the fit of Gaussain distribution and cumulative probability density (CPD), we 
can conclude how many of dynamic population exist for each protein single molecule. 
From the analysis of mean square displacement (MSD) of each single molecule, we 
can get the fraction of each protein population, we can also tell if the protein is bond 
or freely diffusing. From the comparison of diffusion coefficient, we found that MreC, 
MreD and RodZ are colocalized with MreB. We also conclude that PdhC (E2) is the 
core of PDH complex by comparing the diffusion coefficient and the fraction of 
mobile single molecules with other subunits of PDH complex. If we continue the 
research, we can get even more information from the data analysis of single 
molecules. 
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5 Prospects of future study 
There are over 35 autolysins genes in B. subtilis and 3 of them are the mainly 
autolysins for the cell wall but we only studied the major one, LytC, so there is still a 
lot of work to do. For example, in the sporulation process, after the formation of 
spores the mother cell is lysed and the LytC is not responsible for this process so we 
need to figure out which autolysin or how many autolysins can degrade the cross-
linked PG (e.g. LytD can hydrolyze the cross linked PG indicate lytic enzymes can 
also kill the bacteria at stationary phase). So together with LytC, these autolysins 
cannot only inhibit the growth of bacteria but also kill the ones that are in vegetative 
phase. This could bring us to a brighter future of using industrialized proteins as 
potential antibiotics or as ingredients of cosmetics. 
All in all, we open a potential gate to access a new way of antibacterial factors (or 
antibiotics) search, not like the old-fashioned way that managed to find the antibiotics 
that bind to the cell wall biosynthesis machinery and therefore kill the bacteria. For 
these traditional antibiotics, bacteria can easily evolve a pathway that causes the 
antibiotic resistance. We are seeking the enzymes that can degrade cell wall 
components and therefore inhibit bacterial growth and furthermore kill bacteria. The 
advantage of using cell wall breakdown enzymes as the new antibiotics is that 
enzymes do not need to pass through the cell wall and membrane to function (LytC 
can pass through both since the gram-negative bacteria E. coli have the double layer 
cell membrane) which will reduce activity lost. The second reason is that bacteria are 
not prone to develop protein resistance as with the traditional antibiotics. However, to 
use LytC as a new antibiotics in industrial scale and for clinical usage, there is still a 
lot of work that needs to be done, such as the production of LytC must be highly 
enhanced to make sure the industrial usage is profitable. And the side effects also 
need to be checked in case the LytC enzyme causes harm to human beings (even 
though human cells do not have cell wall). Another disadvantage is that LytC can 
only hydrolyze non-cross-linked PG chains so the LytC can only be used to kill the 
growing bacteria. For example, cells that in early exponential phase, therefore we 
need to discover other autolysins that are able to hydrolyze cross-linked PG chains. 
There are over 35 autolysins in B. subtilis so there is a great chance to discover 
another autolysin candidate that can hydrolyze cross-linked PG chains, if combined 
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with LytC they can kill bacteria in all growth phases. We are optimistic that our 
discovery of LytC function can be applied as medicine, for example it can be used for 
some skin disease or used as external medicine. Another potential is that LytC can be 
used as an additive in the cosmetic industry, which could reduce the infection chance 
of skin disease. 
We already obtained much information from the data analysis of single molecules, yet 
we could get even more data if we analyze further. For example, we can get the 
diameter of movement by analyzing the trajectory. We can study the localization of 
proteins with single molecule microscopy, the traditional epifluorescence microscopy 
will not be needed. However, there are also some disadvantages of single molecule 
microscopy. First of all, single molecules are moving rapidly in living cells, even the 
slightest change of cell position could cause great error in single molecule tracking. 
Secondly, the single molecule microscopy was performed in 2 dimensional. But in 
living cell, the molecules could move in a 3 dimensional space. At present, the single 
molecule microscopy is a good tool to study membrane proteins, there are still some 
adjustments need to do for studying cytoplasmic proteins precisely in single molecule 
level. The diameter of bacteria (usually in µm level) is rather shorter than eukaryotes, 
the objective of microscopy can only focus at a small specific region. The focusd 
region (in µm level) of eukaryotes can be treated as flat 2 dimensional layer. Yet for 
bacteria, we usually lose the focus of single molecules at the edges or the poles of 
cells. Therefore, to use the single molecule microscopy technique and the analyzed 
data more widely, more models need to be built and more correction needs to be done 
to obtain more accurate data. 
In our case, there are two categories of protein single molecules in cells, for PDH 
subunits, MreBCD and RodZ constructs. One is the native proteins and another one is 
the constructed proteins. The co-expression of both kind of proteins will lead to the 
over expression of proteins. The proteins that cells needed, for example MreB to form 
the filaments, PdhC to form the core of PDH complex, are unchanged. This will result 
in an excess of protein single molecules in the cells, and the excessive single 
molecules are more likely to diffuse freely in the cells. This is the main source of 
error in our work. In the future, we plan to delete the native genes to make our 
experimental data more matched with the reality. The enzyme activity of each 
 89 
subunits  of PDH complex also needs to be tested because we have both the N-
terminal and the C-terminal fusion and usually only one kind of fusion works, we 
need to illustrate which fusion could maintain the enzyme activity. 
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Appendix 
The single molecule tracking analysis of MreB and PfkA is shown in Figure 36. 
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Figure 36. Single molecule tracking analysis. (A) Track lengths in frames. The X axis stands 
for the frame interval of each spot, the Y axis stands for the number of frame intervals (the 
shortest time interval is 5 frames). (B) Weighted average of all MSD curves. The red fitted 
curve is the superposition MSD curve of two Gaussian distributions. The slope of the red 
curve is the mean diffusion coefficients of two Gaussian distributions. (C) Probability density 
function (PDF) of all tracking displacement in X and Y directions. (D) One population fits of 
Gaussian distribution. (E) Two Gaussian distributions fits of single molecule moving 
behavior. The Y axis represents the density of each kind of moving behavior. The green curve 
stands for the superposition plot of two Gaussian distribution fits (dotted red curve and the 
dashed red curve). Two red curves represent the plot of two populations fit. In E1, the dotted 
red curve represents the immobile population of YFP-MreB, the dashed red curve represents 
the mobile population of YFP-MreB. In E2, two red curves represent two populations of 
mobile PfkA-YFP. (F) CPD (cumulative probability density function) curves of squared 
displacement. The blue curves represent experimental data, the red curve indicates the CPD 
fits data from blue curves, and the black curves represent the residuals between experimental 
data and the fits data. The X axis represents the displacement of spots movement in both X 
and Y direction. The Y axis represents the cumulative density of all displacements. In F1, one 
mobile and one immobile population fitted very well with the YFP-MreB results. In F2, two 
mobile populations fitted very well with the PfkA-YFP results. Images were created by Dr. 
Thomas Rösch. 
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